ESPE Abstracts

Contents

• Plenary Lectures
• • Sex Differences in the Brain: Intersectionality of the Endocrine, Immune and Nervous Systems
  • • Abstract unavailable

      hrp0097pl1
  • The food environment and the global childhood obesity epidemic: The role of ultra-processed food
  • • Abstract unavailable

      hrp0097pl2
  • Structural and functional development of the adolescent brain
  • • Abstract unavailable

      hrp0097pl3
  • How AI will change medicine
  • • Abstract unavailable

      hrp0097pl4
  • Stem cells organoids and single cell transcriptomics
  • • Cracking the pituitary stem cell code across life using single-cell transcriptomics and organoid models

      hrp0097pl5
  • How the genome predicts human disease
  • • Abstract unavailable

      hrp0097pl6
  • Novel approaches in autoimmune endocrine disorders
  • • Abstract unavailable

      hrp0097pl7
  • Real world use of closed loop insulin delivery
  • • Real world use of closed loop insulin delivery

      hrp0097pl8
• Symposia
• • DSD
  • • Life-long care for people with 46,XY DSD

      hrp0097s1.1
    • Studying neglected cell populations of the developing testis and their functions

      hrp0097s1.2
    • Pathogenesis of testicular dysfunction in Klinefelter syndrome

      hrp0097s1.3
  • Hypothalamo-pituitary disorders
  • • Abstract unavailable

      hrp0097s2.1
    • Abstract unavailable

      hrp0097s2.2
    • Abstract unavailable

      hrp0097s2.3
  • Endocrine effects of cancer treatment
  • • Safety of GH treatment in cancer survivors

      hrp0097s3.1
    • Surveillance for Endocrine Disease in Childhood Cancer Survivors

      hrp0097s3.2
    • Fertility preservation in children with cancer

      hrp0097s3.3
  • Novel insights and innovations in diabetes
  • • Abstract unavailable

      hrp0097s4.1
    • Abstract unavailable

      hrp0097s4.2
    • Physical interaction between beta and delta cells

      hrp0097s4.3
  • Hypothalamic syndromes
  • • Abstract unavailable

      hrp0097s5.1
    • Abstract unavailable

      hrp0097s5.2
    • Abstract unavailable

      hrp0097s5.3
  • Neonatal endocrinology
  • • Unravelling the role of epigenetics in reproductive adaptations to early-life environment

      hrp0097s6.1
    • Abstract unavailable

      hrp0097s6.2
    • The developing HPA axis: establishing diurnal variation in cortisol secretion

      hrp0097s6.3
  • Theories of obesity development and their implications on dietary interventions
  • • Competing Paradigms of Obesity Pathogenesis

      hrp0097s7.1
    • Does an adiposity force induce obesity independent of a normal energy balance system?

      hrp0097s7.2
    • Abstract unavailable

      hrp0097s7.3
  • Adrenals
  • • Abstract unavailable

      hrp0097s8.1
    • Diagnosis and Management of Central Congenital Hypothyroidism

      hrp0097s8.2
    • Abstract unavailable

      hrp0097s8.3
  • Thyroid
  • • Abstract unavailable

      hrp0097s9.1
    • Is there a role for combined T4 and T3 therapy in hypothyroidism?

      hrp0097s9.2
    • The role of thyroid hormone transporters in brain development and function

      hrp0097s9.3
  • Bone
  • • Abstract unavailable

      hrp0097s10.1
    • Inherited ectopic calcification disorders

      hrp0097s10.2
    • Abstract unavailable

      hrp0097s10.3
  • Diet, nutrients and the environment
  • • Timing of eating and exercise to improve metabolic health in humans

      hrp0097s11.1
    • Abstract unavailable

      hrp0097s11.2
    • Abstract unavailable

      hrp0097s11.3
  • What's new for the HPG Axis
  • • Minipuberty - Looking into the future

      hrp0097s12.1
    • SEMA6A drives GnRH neuron-dependent puberty onset by tuning median eminence vascular permeability

      hrp0097s12.2
    • Abstract unavailable

      hrp0097s12.3
• Meet the Expert
• • Management of MEN1 in children and adolescents
  • • Abstract unavailable

      hrp0097mte1.1
  • Informing children about their DSD – when and how?
  • • Abstract unavailable

      hrp0097mte2.1
  • Uncertainties around diagnosing growth hormone deficiency?
  • • Abstract unavailable

      hrp0097mte3.1
  • Clinical Management of Prader-Willi Syndrome in infants, children and adolescents
  • • Abstract unavailable

      hrp0097mte4.1
  • Management of Pituitary adenomas in Children
  • • Abstract unavailable

      hrp0097mte5.1
  • Approach to Thyroid cancer in Children
  • • Abstract unavailable

      hrp0097mte6.1
  • Management of hyperinsulism beyond the acute phase
  • • Abstract unavailable

      hrp0097mte7.1
  • Puberty induction in hypogonadism
  • • Abstract unavailable

      hrp0097mte8.1
  • Informing children about their DSD – when and how? (1)
  • • Abstract unavailable

      hrp0097mte2.2
  • Uncertainties around diagnosing growth hormone deficiency? (1)
  • • Abstract unavailable

      hrp0097mte3.2
  • Clinical Management of Prader-Willi Syndrome in infants, children and adolescents (1)
  • • Abstract unavailable

      hrp0097mte4.2
  • Management of Pituitary adenomas in Children (1)
  • • Abstract unavailable

      hrp0097mte5.2
  • Puberty induction in hypogonadism (1)
  • • Abstract unavailable

      hrp0097mte8.2
  • Management of MEN1 in children and adolescents (1)
  • • Abstract unavailable

      hrp0097mte1.2
  • Approach to Thyroid cancer in Children (1)
  • • Abstract unavailable

      hrp0097mte6.2
  • Management of hyperinsulism beyond the acute phase (1)
  • • Abstract unavailable

      hrp0097mte7.2
• How Do I…
• • How Do I… Session 1
  • • Abstract unavailable

      hrp0097hdi1.1
    • Abstract unavailable

      hrp0097hdi1.2
    • Abstract unavailable

      hrp0097hdi1.3
  • How Do I… Session 2
  • • Abstract unavailable

      hrp0097hdi2.1
    • How Do I initiate, support, and follow-up people with T1DM on an automated insulin delivery system?

      hrp0097hdi2.2
    • Diagnosis and management of hypercholesterolemia

      hrp0097hdi2.3
• Controversies
• • Pharmacological manipulation of bone maturation should be used to preserve final height in short children
  • • Pharmacological manipulation of bone maturation should be used to preserve final height in short children (FOR)

      hrp0097con1.1
    • Abstract unavailable

      hrp0097con1.2
• Novel Advances
• • Novel Advances Session
  • • Abstract unavailable

      hrp0097na1.1
    • Abstract unavailable

      hrp0097na1.2
• GPED
• • GPED Symposium
  • • Abstract unavailable

      hrp0097gped1.1
• Young Investigators
• • Section
  • • Abstract unavailable

      hrp0097yi1.1
    • Abstract unavailable

      hrp0097yi1.2
    • Abstract unavailable

      hrp0097yi1.3
• Working Group Symposia
• • ESPE Working Group on Disorders of Sex Development (DSD) Symposium
  • • Abstract unavailable

      hrp0097wg1.1
    • Abstract unavailable

      hrp0097wg1.2
    • Abstract unavailable

      hrp0097wg1.3
    • Abstract unavailable

      hrp0097wg1.4
    • Abstract unavailable

      hrp0097wg1.5
    • Abstract unavailable

      hrp0097wg1.6
    • Abstract unavailable

      hrp0097wg1.7
  • ESPE Working Group on Obesity Symposium
  • • Abstract unavailable

      hrp0097wg2.1
    • Environmental contributions to obesity development

      hrp0097wg2.2
    • Abstract unavailable

      hrp0097wg2.3
    • Abstract unavailable

      hrp0097wg2.4
    • Abstract unavailable

      hrp0097wg2.5
  • ESPE Working Group on Bone and Growth Plate (BGP) Symposium
  • • Abstract unavailable

      hrp0097wg3.1
    • Abstract unavailable

      hrp0097wg3.2
    • Abstract unavailable

      hrp0097wg3.3
  • ESPE Working Group on Diabetes Technology (DT) Symposium
  • • Abstract unavailable

      hrp0097wg4.1
    • Abstract unavailable

      hrp0097wg4.2
    • Abstract unavailable

      hrp0097wg4.3
    • Abstract unavailable

      hrp0097wg4.4
    • Abstract unavailable

      hrp0097wg4.5
  • ESPE Working Group on Paediatric and Adolescent Gynaecology (PAG) Symposium
  • • Abstract unavailable

      hrp0097wg5.1
    • Abstract unavailable

      hrp0097wg5.2
    • Abstract unavailable

      hrp0097wg5.3
  • ESPE Working Group on Gender Dysphoria (GD) Symposium
  • • Abstract unavailable

      hrp0097wg6.1
    • Abstract unavailable

      hrp0097wg6.2
    • Abstract unavailable

      hrp0097wg6.3
  • ESPE Working Group on Turner Syndrome Symposium
  • • Abstract unavailable

      hrp0097wg7.1
    • Abstract unavailable

      hrp0097wg7.2
    • Abstract unavailable

      hrp0097wg7.3
    • Abstract unavailable

      hrp0097wg7.4
    • Abstract unavailable

      hrp0097wg7.5
    • Abstract unavailable

      hrp0097wg7.6
  • ESPE Nursing and Allied Health Working Group (PENS) Symposium
  • • Abstract unavailable

      hrp0097wg8.1
    • Abstract unavailable

      hrp0097wg8.2
    • Abstract unavailable

      hrp0097wg8.3
    • Abstract unavailable

      hrp0097wg8.4
    • Abstract unavailable

      hrp0097wg8.5
    • Abstract unavailable

      hrp0097wg8.6
    • Abstract unavailable

      hrp0097wg8.7
• Ethics in Endocrinology
• • Section
  • • Solidarity and justice in the Dutch Coverage Lock Policy for Expensive Medicines - public Opinions and Stakeholder Perspectives

      hrp0097ee1.1
    • Abstract unavailable

      hrp0097ee1.2
    • Abstract unavailable

      hrp0097ee1.3
    • Abstract unavailable

      hrp0097ee1.4
• Endo-ERN Symposium
• • Section
  • • Abstract unavailable

      hrp0097ern1.1
    • Abstract unavailable

      hrp0097ern1.2
    • Abstract unavailable

      hrp0097ern1.3
    • Abstract unavailable

      hrp0097ern1.4
• ESPE Yearbook Sessions
• • Year of Paediatric Endocrinology 1
  • • Abstract unavailable

      hrp0097yb1.1
    • Abstract unavailable

      hrp0097yb1.2
    • Abstract unavailable

      hrp0097yb1.3
    • Abstract unavailable

      hrp0097yb1.4
    • Abstract unavailable

      hrp0097yb1.5
  • Year of Paediatric Endocrinology 2
  • • Abstract unavailable

      hrp0097yb2.1
    • Abstract unavailable

      hrp0097yb1.2
    • Abstract unavailable

      hrp0097yb2.3
    • Abstract unavailable

      hrp0097yb2.4
    • Abstract unavailable

      hrp0097yb2.5
  • Year of Paediatric Endocrinology 3
  • • Abstract unavailable

      hrp0097yb3.1
    • Abstract unavailable

      hrp0097yb3.2
    • Abstract unavailable

      hrp0097yb3.3
    • Abstract unavailable

      hrp0097yb3.4
    • Abstract unavailable

      hrp0097yb3.5
• Henning Andersen Award Winners
• • An integrated roadmap of human fetal adrenal gland development
  • • An integrated roadmap of human fetal adrenal gland development

      hrp0097ha1
  • Effect of omega-3 fatty acids supplementation on renal glomerular and tubular integrity and subclinical atherosclerosis in children and adolescents with type 1 diabetes: A randomized controlled trial
  • • Effect of omega-3 fatty acids supplementation on renal glomerular and tubular integrity and subclinical atherosclerosis in children and adolescents with type 1 diabetes: A randomized controlled trial

      hrp0097ha2
• Free Communications
• • Adrenals and HPA Axis
  • • Investigating intergenerational effects of glucocorticoids

      hrp0097fc1.1
    • The pathophysiologic response of central nervous system due to differently impaired steroidogenesis

      hrp0097fc1.2
    • Generation and Characterization of a novel Humanized CYP21A2 Knock-in Mouse Model for Congenital Adrenal Hyperplasia

      hrp0097fc1.3
    • Response to Crinecerfont Treatment in Adolescents with Classic Congenital Adrenal Hyperplasia Is Correlated with Elevated Baseline Hormone Concentrations but Not Glucocorticoid Dose

      hrp0097fc1.4
    • Management of congenital adrenal hyperplasia in the first 90 days of life: a multi-centre I-CAH analysis of contemporary practice

      hrp0097fc1.5
    • Cardiovascular risk profile in adult patients with congenital adrenal hyperplasia: a cross-sectional study

      hrp0097fc1.6
  • Bone, Growth Plate and Mineral Metabolism
  • • Hearing loss in pseudohypoparathyroidism (inactivating PTH/PTHRP Signaling Disorder): a prospective study to assess prevalence and predictive factors of hearing loss in 44 patients affected with iPPSD/PHP

      hrp0097fc2.1
    • First Results of the Global ALPL Gene Variant Classification Project

      hrp0097fc2.2
    • Hyperparathyroidism after three years of burosumab in children affected with x-linked hypophosphatemia

      hrp0097fc2.3
    • A real-world study in Germany and Switzerland regarding renal health in children with X-linked hypophosphatemia

      hrp0097fc2.4
    • Generation of novel genetic zebrafish models and using RNA-seq analysis to explore the role of ankrd11 gene on bone growth

      hrp0097fc2.5
    • Human breast milk-derived exosomes promote growth plate cell lines in vitro

      hrp0097fc2.6
  • Fat, metabolism and obesity 1
  • • Early childhood height and weight development in children with monogenic obesity: A European multicenter cohort study

      hrp0097fc3.1
    • Analysis of ligand- and mutation-dependent signaling of the melanocortin 4 receptor (MC4R): an example of the relevance of differential signaling (bias signaling)

      hrp0097fc3.2
    • Frequency of Obesity-Related Gene Variants in a European Population With Early-Onset, Severe Obesity

      hrp0097fc3.3
    • A Novel Mutation in DYRK1B Associated With Abdominal Obesity Metabolic Syndrome 3 (AOMS3)

      hrp0097fc3.4
    • Early corneal nerve loss in children with obesity and type 2 diabetes

      hrp0097fc3.5
    • Impact of Setmelanotide on Future Metabolic Syndrome Risk in Pediatric Patients With Bardet-Biedl Syndrome

      hrp0097fc3.6
  • Growth and syndromes (to include Turner syndrome)
  • • Heterozygous Null Mutations in FLNB as a Cause of apparent isolated Short Stature in Chinese Children

      hrp0097fc4.1
    • Genetic and phenotypic features of children with familial tall stature

      hrp0097fc4.2
    • Pathogenic variants in GHSR cause short stature and growth hormone neurosecretory dysfunction; results from a large case series

      hrp0097fc4.3
    • Growth failure in aggrecan haploinsufficiency is due to a decrease in growth plate matrix volume and hypertrophic cell size

      hrp0097fc4.4
    • From thalidomide embryopathy to genetic defects of the upper limb, internal organs, cerebral midline, and pituitary: The phenotypic spectrum of SALL4

      hrp0097fc4.5
    • Persistence of Growth Promoting Effects in Infants and Toddlers with Achondroplasia: Results in Children Aged Over 2 Years Old from a Phase II Extension Study with Vosoritide

      hrp0097fc4.6
  • Diabetes and insulin 1
  • • Diabetes mellitus and gender incongruence: Worse metabolic control in type 1 and higher mental health issue rates in type 1 and 2 diabetes – a DPV registry study

      hrp0097fc5.1
    • Nailfold capillaroscopy: An alternative non-invasive tool for evaluating microvascular involvement in children with type 1 diabetes

      hrp0097fc5.2
    • How feasible is it to meet the Time in Tight Range (TITR) target with Automatic Insulin Delivery (AID)?: 2128-day real-world data from a single center

      hrp0097fc5.3
    • Changes of intestinal flora in children with type 1 diabetes mellitus and its related immune mechanism

      hrp0097fc5.4
    • Sleep Characteristics, Glycemic Control, and Endothelial Function in Adolescents and Young Adults with Type 1 Diabetes

      hrp0097fc5.5
    • Post-Hypoglycemic Hyperglycemia Are Highly Relevant Markers For Stratification Of Glycemic Variability and Remission Status Of Pediatric Patients With New-Onset Type 1 Diabetes

      hrp0097fc5.6
  • Pituitary, neuroendocrinology and puberty 1
  • • Methylome analysis in idiopathic central precocious puberty girls

      hrp0097fc6.1
    • The role of body composition and appetite-regulating hormones in idiopathic central precocious puberty and their changes during GnRH analogue therapy

      hrp0097fc6.2
    • Is the 24-hour urinary gonadotropin assay an effective diagnostic tool in central precocious puberty? A retrospective study of threshold setting and validation in two cohorts

      hrp0097fc6.3
    • Sleeptime-excreted total urinary luteinizing hormone concentrations reveal that the onset of central puberty occurs at around the same time in boys and girls: a longitudinal study

      hrp0097fc6.4
    • Clinical characteristics of 213 children with early pubertal development complicated with pineal cyst

      hrp0097fc6.5
    • Serum Kisspeptin and DLK1 levels as a tool for diagnosis and monitoring of central precocious puberty treatment in Thai girls

      hrp0097fc6.6
  • Sex differentiation, gonads and gynaecology or sex endocrinology
  • • Polygenic scores for testosterone and SHBG are associated with hormone levels in male infants

      hrp0097fc7.1
    • Mapping the transcriptomic landscape of early human fetal ovary development through a clinically-focused lens

      hrp0097fc7.2
    • ROS scavengers may improve genital skin healing in boys with hypospadias

      hrp0097fc7.3
    • The effect of common genetic variants in CYP19A1 on serum Estradiol to Testosterone Ratio in healthy Danish children and adolescents

      hrp0097fc7.4
    • SGPL1 deficiency, a cause of 46XY DSD and adrenal insufficiency, impairs lipid metabolism and steroidogenesis in Leydig cells

      hrp0097fc7.5
    • GnRHa response patterns of testis expressed genes in cryptorchid boys

      hrp0097fc7.6
  • Fat, metabolism and obesity 2
  • • Aberrant expression of agouti signaling protein (ASIP) as a new cause of monogenic severe childhood obesity

      hrp0097fc8.1
    • Frequency of MC4R Pathway Variants in a European Cohort of Individuals With Early-Onset Severe Obesity

      hrp0097fc8.2
    • Impact of growth hormone therapy on body mass index in childhood-onset craniopharyngioma: a multicenter Italian study in 117 patients

      hrp0097fc8.3
    • Irs1 expression in peripheral blood associates with obesity and cardiovascular risk parameters in school-age girls

      hrp0097fc8.4
    • Impact of Setmelanotide on Metabolic Syndrome Risk in Pediatric Patients With POMC and LEPR Deficiency

      hrp0097fc8.5
    • Liraglutide treatment in adolescents with extreme obesity - Effects on weight loss in the first 9 months under real-life conditions

      hrp0097fc8.6
  • Diabetes and insulin 2
  • • Reference values for the insulin response to glucose challenge enable the early detection of emerging (pre)diabetes in children and young adults with obesity

      hrp0097fc9.1
    • Characterization of pediatric patients with type 2 diabetes and trends in their pharmaceutical management 2000-2022 in German-speaking countries: Analysis based on the DPV registry

      hrp0097fc9.2
    • A novel case of hypoglycaemia secondary to a pro-insulin processing disorder

      hrp0097fc9.3
    • The high proportion of INS-MODY in Chinese children with MODY

      hrp0097fc9.4
    • A case of NARS1 deficiency resulting in diabetes mellitus with liver cirrhosis and pancreatic atrophy

      hrp0097fc9.5
    • Puberty and Gonadal function in Wolfram Syndrome: A retrospective single centre study

      hrp0097fc9.6
  • Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
  • • Dasiglucagon safety in paediatric participants with CHI

      hrp0097fc10.1
    • Immune profile response to rituximab in ROHHAD syndrome

      hrp0097fc10.2
    • ROHHAD syndrome, thrombotic risk and endothelial damage: a single center experience

      hrp0097fc10.3
    • A Novel Mutation in RAI1 Gene in a Patient with Clinical Diagnosis of Rapid-Onset Obesity with Hypothalamic Dysregulation, Hypoventilation, and Autonomic Dysregulation (ROHHAD) Syndrome with Overlapping Symptoms of Smith Magenis Syndrome (SMS).

      hrp0097fc10.4
    • MCM4 deficiency causing Natural Killer and Glucocorticoid Deficiency with DNA repair defect (AR-NKGCD) - a large cases series from the Irish Traveller population

      hrp0097fc10.5
    • Placental mest gene expression is associated with postnatal growth and obesity

      hrp0097fc10.6
  • GH and IGFs
  • • GH replacement therapy with once-weekly somapacitan in children with GH deficiency is effective and well-tolerated: 2-year results from REAL4

      hrp0097fc11.1
    • Clinical characteristics of heterozygous ACAN gene variants and longer-term response to growth hormone treatment: real-world data

      hrp0097fc11.2
    • Analysis of a large panel of genes in a cohort of patients with severe short stature: detection rate and genotype-phenotype correlations

      hrp0097fc11.3
    • Long-term GH-treatment of children born small for gestational age (SGA) does not result in cerebrovascular abnormalities in adulthood compared to untreated controls

      hrp0097fc11.4
    • Effective GH Replacement with Once-weekly Somapacitan in Japanese Children with GH Deficiency: 2-year Results from REAL4

      hrp0097fc11.5
    • Longitudinal analysis of the risk of brain tumour recurrence or progression in relation to the timing of commencement of growth hormone replacement therapy

      hrp0097fc11.6
  • Thyroid
  • • Graves’ disease – are we just delaying the inevitable?

      hrp0097fc12.1
    • Thyroid function analysis in 48 patients affected by severe combined immunodeficiency caused by adenosine deaminase deficiency

      hrp0097fc12.2
    • Hypothyroidism due to IYD bi-allelic pathogenic variants: clinical description of eight patients

      hrp0097fc12.3
    • Thyroid hormone resistance due to THRB gene mutations: neonatal manifestations in two cases

      hrp0097fc12.4
    • Teprotumumab in an adolescent with severe corticosteroid-resistant Graves ophthalmopathy: success but unexpected neurological manifestations

      hrp0097fc12.5
    • TSH screening in premature newborns: a critical appraisal of the value of a second sample

      hrp0097fc12.6
  • Pituitary, neuroendocrinology and puberty 2
  • • Genetic evaluation in children with self-limited pubertal delay discloses new candidate genes

      hrp0097fc13.1
    • Targeted gene panel screening in 144 congenital hypopituitarism patients, incorporating 135 known and novel genes implicated in hypopituitarism and/or hypothalamo-pituitary development

      hrp0097fc13.2
    • Variants in Methyl-CpG-binding protein 2 (MECP2) are associated with X-Linked Central Precocious Puberty

      hrp0097fc13.3
    • Clinical and molecular genetic characteristics of 98 patients with congenital hypopituitarism: A single-center experience

      hrp0097fc13.4
    • Systematic review and meta-analysis of spermatogenesis rates after pubertal induction with gonadotropins in males with hypogonadotropic hypogonadism

      hrp0097fc13.5
    • Effects of Blue Light Exposure and Exposure Duration on Male Rats Puberty Process

      hrp0097fc13.6
  • Late Breaking
  • • Sleep health characteristics in children with congenital adrenal hyperplasia

      hrp0097fc14.1
    • New Reference Values for Thyroid Volume by Ultrasound in German Children and Adolescents Under Iodine-Sufficient Conditions From a Nationwide Study

      hrp0097fc14.2
    • Deconvolution Analysis: GH secretagogue (LUM-201) enhances growth in individuals with moderate idiopathic Pediatric Growth Hormone Deficiency (iPGHD) by enhancing endogenous GH secretion and increasing IGF-1

      hrp0097fc14.3
    • Improvement in insulin sensitivity and glucose metabolism in adolescents with obesity treated with once-weekly semaglutide 2.4 mg: a secondary analysis of the STEP TEENS trial

      hrp0097fc14.4
    • Predicting Average IGF-I Concentration for Once-Weekly Somapacitan in Children with Growth Hormone Deficiency

      hrp0097fc14.5
    • Understanding the genetic complexity of puberty timing across the allele frequency spectrum

      hrp0097fc14.6
• Rapid Free Communications
• • Adrenals and HPA Axis
  • • Unfavorable Body Composition in Children with Premature Adrenarche: Implications for Metabolic Health

      hrp0097rfc1.1
    • The chimeric CYP21A1P/CYP21A2 and TNXA/TNXB gene deficiencies in patients with Congenital Adrenal Hyperplasia

      hrp0097rfc1.2
    • The effect of storage and temperature on the stability of steroid hormones in dried blood spots

      hrp0097rfc1.3
    • Lack of NAD(P)⁺ transhydrogenase activity in patients with primary adrenal insufficiency due to NNT mutations

      hrp0097rfc1.4
    • Clinical and Genetic Characteristics of 42 Chinese Paediatric Patients with X-Linked Adrenal Hypoplasia Congenita

      hrp0097rfc1.5
    • Interlaboratory comparison of LC-MS/MS measurements of 11 relevant steroid hormones in 27 DSD patients

      hrp0097rfc1.6
  • Bone, Growth Plate and Mineral Metabolism
  • • Identification of novel genes including NAV2 associated with isolated tall stature

      hrp0097rfc2.1
    • Familial pseudohypoparathyroidism type IB associated with an SVA retrotransposon insertion in the GNAS locus

      hrp0097rfc2.2
    • High incidence of Chiari type I anomalies on MRI in young patients with X-linked hypophosphatemic rickets (XLHR)

      hrp0097rfc2.3
    • Documentation of inactivating PTH/PTHrP Signaling Disorders (Pseudohypoparathyroidism) cases in EuRRECa / EuRR-Bone: a challenging, but worthwhile journey

      hrp0097rfc2.4
    • Growth in young children with X-linked hypophosphatemia treated with burosumab

      hrp0097rfc2.5
    • Short term side effects of first bisphosphonate infusion in children with different underlying bone pathologies

      hrp0097rfc2.6
  • Fat, metabolism and obesity 1
  • • Fasting and meal-related zonulin serum levels in a large cohort of obese children and adolescents: a cross sectional study

      hrp0097rfc3.1
    • Reduced central sensitivity to thyroid hormones in children and adolescents with overweight or obesity and impaired glucose tolerance

      hrp0097rfc3.2
    • Early Corneal Nerve Loss in Children with Melanocortin 4 Receptor (MC4R) Gene Mutation Related Obesity

      hrp0097rfc3.3
    • Effect of maternal diet and breastfeeding on growth and distribution of adiposity from birth up to 12 months: data from the European LIFE-MILCH project

      hrp0097rfc3.4
    • Multi-omics Reveals molecule target Underlying Adolescent obesity with metabolic syndrome

      hrp0097rfc3.5
    • Glucocorticoid-mediated leptin secretion from human adipocytes is dependent on glucose availability

      hrp0097rfc3.6
  • Growth and syndromes (to include Turner syndrome)
  • • Functional networks reveal pathways linking early growth to childhood blood pressure in the Manchester BabyGRO Study

      hrp0097rfc4.1
    • Molecular genetic diagnosis in children with Idiopathic Short Stature: Single Center Experience

      hrp0097rfc4.2
    • Aromatase inhibitors: an effective and safe option for height increment in boys with growth hormone deficiency?

      hrp0097rfc4.3
    • Genetic findings in short Turkish children born to consanguineous parents

      hrp0097rfc4.4
    • Real-world safety and effectiveness of vosoritide: Results from an early access program in France

      hrp0097rfc4.5
    • Results from the PROPEL 2 dose-finding study: oral infigratinib leads to significant increases in height velocity with good tolerability in children with achondroplasia

      hrp0097rfc4.6
  • Diabetes and insulin 1
  • • Tear proteomics profile in children and adolescents with type 1 diabetes mellitus

      hrp0097rfc5.1
    • Comparison of Optical Coherence Tomography Angiography Findings in Children with Type 1 Diabetes Mellitus and Autoimmune Thyroiditis with Healthy Children

      hrp0097rfc5.2
    • 3 Screen ICA ELISA–A new tool to identify pre-clinical diabetes in first-degree relatives of patients with type 1 diabetes (pre-d1abetes study)

      hrp0097rfc5.3
    • Effect of probiotic on glycemic control in children with type 1 diabetes: A randomized controlled trial

      hrp0097rfc5.4
    • Syndrome of hypoglycemia unawareness in children with type 1 diabetes: clinical contribution of Clark and Gold questionnaire

      hrp0097rfc5.5
    • Do females with Type 1 Diabetes have puberty earlier?

      hrp0097rfc5.6
  • Pituitary, neuroendocrinology and puberty 1
  • • Clinical application of LH cut-off value in the diagnosis of CPP according to the international consensus

      hrp0097rfc6.1
    • Psychosocial Evaluation of Girls with Rapidly Progressive Puberty Presenting with Early Menarche

      hrp0097rfc6.2
    • Exposure to Per- and Polyfluoroalkyl Substances and Pubertal Assessment by Ultrasound in Norwegian Boys and Girls: Data from the Bergen Growth Study 2

      hrp0097rfc6.3
    • Earlier Occurrence of Puberty and Pubertal Hair Development in Boys and Girls - Insights from the DPV Initiative Data

      hrp0097rfc6.4
    • Efficacy and security of gonadotropin treatment in adolescents with congenital hypogonadotropic hypogonadism

      hrp0097rfc6.5
    • Evaluation of Serum MKRN3 and DLK1 Concentrations for Predicting Variant Detection in MKRN3 and DLK1Genes in Patients with Central Precocious Puberty

      hrp0097rfc6.6
  • Sex differentiation, gonads and gynaecology or sex endocrinology
  • • Penile width increases more clearly than penile length during minipuberty: a longitudinal study of 136 healthy infant boys

      hrp0097rfc7.1
    • International Evidence-Based Guidelines for PCOS 2023: Recommendations in Adolescent Girls

      hrp0097rfc7.2
    • Histone code, cryptorchidism, infertility

      hrp0097rfc7.3
    • Serum steroid metabolome dynamics during infancy: a prospective, longitudinal cohort of healthy boys

      hrp0097rfc7.4
    • Sex differences in endocrine mechanisms during early human fetal brain development

      hrp0097rfc7.5
    • Prenatal AnoGenital Distance (AGD) by ultrasonography in 571 fetuses and correlation to postnatal AGD: A longitudinal cohort study of healthy males and females

      hrp0097rfc7.6
  • Fat, metabolism and obesity 2
  • • A novel heterozygous likely pathogenic variant in GNB1 causing hyperphagia, severe early onset obesity and neurodevelopmental disorder

      hrp0097rfc8.1
    • Acute rise of leptin after five days of dexamethasone and its association with hunger, fat mass, sleep and fatigue, in children with acute lymphoblastic leukemia

      hrp0097rfc8.2
    • Higher levels of serum α-Klotho are longitudinally associated with less visceral fat accumulation in apparently healthy girls experiencing weight gain

      hrp0097rfc8.3
    • Understanding the genetics of early onset obesity in a cohort of children from Qatar

      hrp0097rfc8.4
    • Effects of leptin knockdown on a human preadipocyte model

      hrp0097rfc8.5
    • Leukocytes and Neutrophil–Lymphocyte Ratio as Indicators of decreased insulin sensitivity in NGT Overweight and Obese Children with high 1-hour post-load plasma glucose levels

      hrp0097rfc8.6
  • Diabetes and insulin 2
  • • The association of dietary glycemic index and load with insulin sensitivity and secretion from early childhood to late adolescence: the QUALITY cohort

      hrp0097rfc9.1
    • Two new candidate genes, OGDH and FGFR1 discovered in an insulinoma from a fifteen-year-old male

      hrp0097rfc9.2
    • Impaired Insulin Secretion as a Pathophysiology Underlying Abnormal Glucose Metabolism in Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors: A Study Comparing Glucose Metabolism between ALL Survivors and Simple Obese Children

      hrp0097rfc9.3
    • Clinical and genetic characteristics of patients suspected to have Maturity-Onset Diabetes of the Young in the Czech Republic

      hrp0097rfc9.4
    • Insulin secretion defect in children and adolescents with obesity: Clinical and molecular genetic characterization

      hrp0097rfc9.5
    • Wharton jelly derived mesenchymal stem cells exosomes protect pancreatic beta cells from inflamation

      hrp0097rfc9.6
  • Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
  • • A novel maternally inherited GNAS variant in a family with hyperphagia and obesity

      hrp0097rfc10.1
    • Utility of Continuous Glucose Monitoring (CGM) during pancreatic surgery in patients with Congenital Hyperinsulinism

      hrp0097rfc10.2
    • Non-coding Variants in HK1 Account for 5% of Cases of Congenital Hyperinsulinism Without an Identified Genetic Cause

      hrp0097rfc10.3
    • Clinical phenotypes of a multicentric cohort of ROHHAD patients

      hrp0097rfc10.4
    • Insulinoma in childhood: A multicenter retrospective study of 28 patients

      hrp0097rfc10.5
    • Two novel mutations in the DCAF17 gene in two Palestinian families with primary amenorrhea revealing molecular genetics in Woodhouse-Sakati syndrome & unique presentation

      hrp0097rfc10.6
  • GH and IGFs
  • • The genetic aetiology of primary multiple pituitary hormone deficiency: a next-generation sequencing analysis of a single-centre cohort

      hrp0097rfc11.1
    • Are pappalysins and stanniocalcins involved in modifying the bioavailability of IGF-I in children with onset of type 1 diabetes mellitus?

      hrp0097rfc11.2
    • Longitudinal assessment of health-related quality of life (HRQoL) & behavior in adults born small for gestational age (SGA) who were treated with growth hormone during childhood

      hrp0097rfc11.3
    • Functional analysis of a novel mutation of IGF1R gene in two twins with growth failure. An example of genotype-phenotype heterogeneity

      hrp0097rfc11.4
    • Influence of sirtuin 1 and fibroblast growth factor 21 levels on IGF-1 concentration in children with short stature of different etiology

      hrp0097rfc11.5
    • Evaluation Of The Growth Hormone-Insulin like Growth Factor1 Axis And Serum Fibroblast Growth Factor 21 Levels As Related To Stature In Children And Adolescents With Coeliac Disease Adherent To Gluten Free Diet

      hrp0097rfc11.6
  • Thyroid
  • • Macro-TSH IgG complex in a case of Congenital Hypothyroidism (CH)

      hrp0097rfc12.1
    • A novel frameshift mutation in Immunoglobulin Superfamily, Member 1 (IGSF1) causing central hypothyroidism, delayed puberty and GH deficiency

      hrp0097rfc12.2
    • Thyroid disorders in childhood cancer survivors treated with 131 I-MIBG, TKIs or immune checkpoint inhibitors: incidence, mechanisms and clinical management – systematic review

      hrp0097rfc12.3
    • Polyethylene glycol thyroid stimulating hormone (PEG-TSH) in real-life: a practical tool for solving a biochemical dilemma

      hrp0097rfc12.4
    • Application of Shear Wave Elastography (SWE) in the ultrasound evaluation of thyroid nodules in children and adolescents

      hrp0097rfc12.5
    • Phenylbutyrate treatment of three patients with Monocarboxylate Transporter 8 deficiency

      hrp0097rfc12.6
  • Pituitary, neuroendocrinology and puberty 2
  • • Are Glucagon-like peptide-1 (GLP-1) receptor agonists a new treatment option for hypothalamic obesity in the paediatric population: Preliminary experience from a tertiary paediatric endocrine centre

      hrp0097rfc13.1
    • Arginine-stimulated copeptin is independent of GH secretion status

      hrp0097rfc13.2
    • Treatment and outcome of the Dutch Childhood Craniopharyngioma Cohort study; first results after centralization of care

      hrp0097rfc13.3
    • Trio analyses of patients with congenital hypopituitarism reveals novel candidate genes

      hrp0097rfc13.4
    • Growth hormone and TSH deficiency after [177Lu]Lu-DOTATATE therapy for pediatric neuroblastoma; description of a first case

      hrp0097rfc13.5
    • Pituitary size on volumetric MRI predicts the severity of the neuroendocrine phenotype in populations at risk

      hrp0097rfc13.6
  • Late Breaking
  • • Clinical characteristics of patients presented with primary adrenal insufficiency due to a p.R451W mutation in the CYP11A1 gene

      hrp0097rfc14.1
    • No Relationship Between Thyroid Function and ADHD – Results From a Nationwide Prospective Epidemiological Study and Mendelian Randomization

      hrp0097rfc14.2
    • Body composition in a pediatric population with type 1 diabetes mellitus - the importance of planned physical activity

      hrp0097rfc14.3
    • Evaluating the Effect of Recombinant Human Growth Hormone Treatment on Sleep-related Breathing Disorders in Toddlers with Prader–Willi Syndrome: a one-year retrospective cohort study

      hrp0097rfc14.4
    • Functional demonstration that variants in the C-terminal of IHH cause short stature and/brachdactyly

      hrp0097rfc14.5
    • Enhanced histones acetylation in children with obesity: relationship with insulin resistance and inflammation

      hrp0097rfc14.6
• Top 20 Posters
• • Section
  • • Molecular and clinical studies in 84 patients with pseudohypoparathyroidism type 1B

      hrp0097t1
    • Effects of tiratricol treatment withdrawal in MCT8 deficiency: ReTRIACt Trial

      hrp0097t2
    • Prevalence of selected polymorphisms of Il7R, CD226, CAPSL and CLEC16A genes in children and adolescents with autoimmune thyroid diseases

      hrp0097t3
    • Functional characterization of novel MC4R gene variant in two unrelated patients with morbid obesity

      hrp0097t4
    • Clinical relevance of findings of the NGS panel for the pediatric patient with papillary thyroid carcinoma

      hrp0097t5
    • Granulosa cell tumors in girls: Preliminary results of a meta-analysis of new and published cases

      hrp0097t6
    • Variants in the Neurodevelopmental Gene Bone Morphogenic Protein/Retinoic Acid Inducible Neural-Specific 2 (BRINP2) are Associated with Severe Delayed Puberty

      hrp0097t7
    • Design and Objectives of the Acorn Study: A Non-Interventional Study Evaluating Long-term Safety in Achondroplasia Patients Treated with Vosoritide

      hrp0097t8
    • Early metabolic risk factors in children with 21 Hydroxylase Deficiency (21OHD): a case-control study

      hrp0097t9
    • Long term effects at 3-4 years of age of early intranasal oxytocin treatment in infants with Prader-Willi syndrome

      hrp0097t10
    • The serum steroid signature of PCOS hints at the involvement of novel pathways for excess androgen biosynthesis

      hrp0097t11
    • Correlation between Metabolites of phthalate and Obese trends in Korean Children and Adolescents using Nationwide data

      hrp0097t12
    • Single-nuclei RNA sequencing reveals potential mechanisms of ovarian insufficiency in 45,X Turner Syndrome

      hrp0097t13
    • Circulating Progranulin in Human Infants: Relation to Prenatal Growth and Early Postnatal Nutrition

      hrp0097t14
    • Cognitive evaluation in children with 21 Hydroxylase Deficiency (21-OHD)

      hrp0097t15
    • Dose dependent risks of glucocorticoid treatment in classic CAH

      hrp0097t16
    • Deterioration in polysomnographic evaluation after COVID-19 infection in patients with Prader-Willi-Syndrome

      hrp0097t17
    • Pubertal origin of growth retardation in Inborn Errors of Protein Metabolism: A longitudinal cohort study

      hrp0097t18
    • Pre-treatment Blood Transcriptome Predicts Growth Response to Somapacitan Treatment in Children Born Small for Gestational Age

      hrp0097t19
    • Hyperparathyroidism is associated with inferior event free survival in lymphatic childhood malignancies in a single center retrospective analysis

      hrp0097t20
• Poster Category 1
• • Adrenals and HPA Axis
  • • Circulating miRNA profile in adrenarche

      hrp0097p1-1
    • Metabolic effects of cortisol insufficiency are sex-depended in a zebrafish model of 21-hydroxylase deficiency

      hrp0097p1-2
    • Acute Adrenal Insufficiency Related Adverse Events In Children With Congenital Adrenal Hyperplasia (CAH): Changes During The Period 2019-2022 In I-CAH

      hrp0097p1-3
    • Major importance of genetic background in cortisol metabolism: Salivary diurnal glucocorticoid profiles in monozygotic twins with intra-twin birthweight-differences

      hrp0097p1-4
    • Glucose profiles of children with classical congenital adrenal hyperplasia: lesson from continuous glucose monitoring

      hrp0097p1-5
    • A retrospective analysis of children and youth with congenital adrenal hyperplasia treated with hydrocortisone modified-release hard capsules

      hrp0097p1-6
    • The process of knowledge-making with a patient encounter – from education to negotiation of the way of treatment in patients with congenital adrenal hyperplasia (CAH)

      hrp0097p1-7
    • Congenital Adrenal Hyperplasia (CAH): Situation and Possibility to Develop a Newborn Screening in Indonesia -- An Exploratory Study

      hrp0097p1-8
    • The @MATES4Kids Movement: Reducing Preventable Mortality Associated with Congenital Adrenal Hyperplasia (CAH) by 30% by 2030

      hrp0097p1-9
    • Endocrinological, genetic and immunological features of a long-term survivor with MIRAGE syndrome

      hrp0097p1-10
    • Girls with Premature Adrenarche but not SGA Reach Their Target Height

      hrp0097p1-11
    • Growth and Metabolic Syndrome (MetS) Criteria in children with Classic Congenital Adrenal Hyperplasia (CAH) treated with corticosteroids (CS) versus normal obese children.

      hrp0097p1-12
    • Epidemiology and causes of primary adrenal insufficiency in children: A population-based study

      hrp0097p1-13
    • Use of Aromatase inhibitors to improve height outcomes in children with Congenital Adrenal Hyperplasia due to 21 hydroxylase deficiency

      hrp0097p1-14
    • Abstract unavailable

      hrp0097p1-15
    • Evaluation of chromatin remodeling factors ATRX and DAXX and telomeres in pediatric adrenocortical tumors

      hrp0097p1-200
    • Molecular characterization of TNXA/TNXB chimeras in cases carrying deletion of the CYP21A2 gene: High incidence of chimeras identified

      hrp0097p1-201
    • Increased adiposity and insulin resistance negatively affect growth in pre-pubertal heterozygote carriers of 21-Hydroxylase deficiency

      hrp0097p1-202
    • Adrenal insufficiency due to bioinactive ACTH caused by novel POMC variants

      hrp0097p1-203
    • Longitudinal Changes in Serum DLK1 Concentrations During Minipuberty in Healthy Infant Girls; Association to Changes in Linear Growth and Fat Mass

      hrp0097p1-204
    • Effects of hyperandrogenism on psychological perception and quality of life in patients with non-classical congenital adrenal hyperplasia

      hrp0097p1-205
    • Adrenal insufficiency is not a common cause of hypoglycemia in children

      hrp0097p1-206
    • Health-Related Quality of Life in Children with Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis

      hrp0097p1-207
    • Genotype-Specific Cortisol Reserve in a Cohort of Subjects with Non-Classic Congenital Adrenal Hyperplasia (NCCAH)

      hrp0097p1-208
    • Successful transition in Congenital Adrenal Hyperplasia - A single centre experience over 20 years

      hrp0097p1-209
    • Change of Thyroid Volume in the Treatment of Congenital Primary Hypothyroidism

      hrp0097p1-210
    • Salivary 11-oxygenated 19-carbon steroids in children with congenital adrenal hyperplasia and Addison's disease compared to healthy children

      hrp0097p1-211
    • Features of allel variants of congenital adrenal hyperplasia in kazakhstan children of different ethnic groups

      hrp0097p1-212
    • Transcriptome profiling evaluation of pediatric adrenocortical tumors (pACT) reveals a favorable-prognosis transcription signature and potential therapeutic targets

      hrp0097p1-399
    • 11-oxygenated androgens as biomarkers in congenital adrenal hyperplasia: reference intervals for children

      hrp0097p1-400
    • Impact of Newborn Screening for Congenital Adrenal Hyperplasia (CAH) on Adult Height: Data from the CAH Registry of the German Society for Pediatric and Adolescent Endocrinology and Diabetology (DGPAED)

      hrp0097p1-401
    • Micronodular bilateral adrenal hyperplasia: about 2 cases in early childhood

      hrp0097p1-402
    • Pediatric Cushing`s disease due to somatic USP8 mutations

      hrp0097p1-403
    • Nephrocalcinosis: an emerging issue in children with Congenital Adrenal Hyperplasia

      hrp0097p1-404
    • Multicenter study on clinical, biochemical and ultrasonographic characteristics, therapeutic management and outcome of TART in males with congenital adrenal hyperplasia

      hrp0097p1-405
    • Congenital adrenal hyperplasia due to 11 β-hydroxylase deficiency: Clinical, Biochemical and Genetic characteristics

      hrp0097p1-406
    • 17OHP levels to diagnose Non-Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency (NC-CAH) in children with precocious pubarche

      hrp0097p1-407
    • Primary Adrenal Insufficiency in Children: Genetic and Clinical Characterization of a Large Cohort in Thailand

      hrp0097p1-408
    • Hydrocortisone (HC) versus Prednisone(P) Therapy in treating Children with Classic Congenital Adrenal Hyperplasia (CAH): Impact on statural growth weight gain and metabolic criteria

      hrp0097p1-409
    • Patient education for management of sick day episodes in adrenal insufficiency: A systematic review of structured education and online patient resources

      hrp0097p1-410
  • Bone, Growth Plate and Mineral Metabolism
  • • Low bone mineral density in children with Cerebral Palsy and its risk factors: finding a way to prevent secondary osteoporosis

      hrp0097p1-16
    • Dual-X-ray-Absorptiometry (DXA) bone parameters in children with Achondroplasia

      hrp0097p1-17
    • Bone mineral density in children and adolescents with Cystic Fibrosis: a follow-up study

      hrp0097p1-18
    • Bone mineral density development in children with chronic non-bacterial osteomyelitis treated with zoledronate

      hrp0097p1-19
    • Non-Osteogenesis Imperfecta Primary Osteoporosis in Children: Clinical and Genetic Features

      hrp0097p1-20
    • Serum osteocalcin, sclerostin and lipocalin-2 levels in adolescent boys with obesity over 12 week sprint interval training

      hrp0097p1-21
    • Fibroblast growth factor receptor-3 (FGFR3) mutation frequency in 17 Albanian children who were clinically to have Achondro – Hypochondroiplasia

      hrp0097p1-22
    • Accelerated linear growth in children with selective tyrosine kinase inhibitior treatment: Hints to a growth factor and sex steroid independent growth promotion mechanism

      hrp0097p1-23
    • Cortical hyperostosis in an infant on prolonged prostaglandin infusion: a case report

      hrp0097p1-24
    • A case of hypophosphatasia accompanying neurofibromatosis type 1

      hrp0097p1-25
    • Bone mineral density of children with cow milk allergy

      hrp0097p1-26
    • Treatment with Letrozole was safe and effective in the case of congenital adrenal hyperplasia

      hrp0097p1-27
    • Effects of romosozumab on bone ultrastructure and density in a patient with primary osteoporosis caused by a novel heterozygous WNT1 mutation

      hrp0097p1-28
    • An adolescent boy with PLS3 mutation causing severe thoracic kypho-scoliosis

      hrp0097p1-29
    • A Novel Stop Codon Mutation in Exon 6 (c.508A>T) of TRAPPC2 gene in a Patient with X-Linked Spondyloepiphyseal Dysplasia Tarda: A Case Report

      hrp0097p1-30
    • Age at diagnosis of XLH amongst children with and without a family history: Findings from the International XLH Registry

      hrp0097p1-213
    • Vitamin-D Dependent Rickets: a case series with presentation, clinical features and long term follow up

      hrp0097p1-214
    • Clinical and genetic characteristics of primary hypoparathyroidism in children：two-center experience in China

      hrp0097p1-215
    • Genetic Evaluation in a cohort of children affect by idiopatic short stature

      hrp0097p1-216
    • Abstract unavailable

      hrp0097p1-217
    • Osteoporosis pseudoglioma syndrome: a case report of a child with osteoporosis and impaired vision

      hrp0097p1-218
    • An investigation of vitamin D deficiency in children with new onset type 1 diabetes mellitus from Henan Province, China

      hrp0097p1-219
    • Evaluation of Bone mineral density and Nutritional status in children with Spastic Cerebral Palsy. Implications for Fracture risk and Quality of Life

      hrp0097p1-220
    • Celiac disease in a patient with Sclerosteosis: an association or just a co-incidence?

      hrp0097p1-221
    • Height evaluation in a group of patients with Prader Willi syndrome after 3 years of treatment with growth hormone

      hrp0097p1-222
    • A rare cause of hypoparathyroidism: Barakat syndrome

      hrp0097p1-223
    • Metaphyseal Dysplasia, Spahr Type: 12-Year Follow-up

      hrp0097p1-224
    • Acrodysostosis: a case report

      hrp0097p1-225
    • Hereditary Vitamin D Resistant Rickets (HVDRR) Case Series: Phenotype, Genotype, Conventional Treatment and Cinacalcet Therapy

      hrp0097p1-226
    • Parathyroid Adenoma in a 12-year- old Child: A Case with Unusual Presentation

      hrp0097p1-227
    • The European Registries for Rare Bone and Mineral Conditions (EuRR-Bone): Collecting Core Data Elements and Clinician and Patient-Reported Outcomes

      hrp0097p1-411
    • Juvenile Paget's Disease: Evaluation of Novel Mutation and Treatment Response

      hrp0097p1-412
    • Obesity and Insulin Resistance in Patients with Achondroplasia

      hrp0097p1-413
    • Multidisciplinary approach in achondroplasia – real world experience after drug approval of vosoritide

      hrp0097p1-414
    • EuRR-Bone: Collecting Condition-Specific Outcomes on Fibrous Dysplasia/ McCune-Albright Syndrome

      hrp0097p1-415
    • Treatment dilemma in a prepubertal patient with ACAN mutation but without advanced bone age

      hrp0097p1-416
    • Executive function, intelligence and bone mineral density: Do associations exist in childhood?

      hrp0097p1-417
    • Comparison of efficacy and safety of oral cholecalciferol administration at 4-week intervals and daily administration to correct vitamin D deficiency in adolescents

      hrp0097p1-418
    • Evaluation of the pediatric patients diagnosed with secondary osteoporosis

      hrp0097p1-419
    • Exploring Childhood Hypoparathyroidism: Stepwise Genetic Evaluation Approach

      hrp0097p1-420
    • Bisphosphonate, sirolimus, atenolol treatment in a 4-year old child diagnosed with Gorham-Stout disease

      hrp0097p1-421
    • Stüve-Wiedemann syndrome: an extremely rare disorder causing recurrent fractures

      hrp0097p1-422
    • Craniosynostosis in hypophosphatasia

      hrp0097p1-423
    • Spondyloepiphyseal dysplasia tarda in a 10 years old boy treated for growth hormone deficiency

      hrp0097p1-424
    • Recombinant human growth hormone treatment for osteogenesis imperfecta: report of two cases

      hrp0097p1-425
    • COMP Gene Variant causing short stature and skeletal dysplasia

      hrp0097p1-426
  • Diabetes and Insulin
  • • Metabolic trajectories during treatment of diabetic ketoacidosis described by breath analysis

      hrp0097p1-31
    • Continuous Glucose Monitoring: A possible aid to detect hypoglycemia event during insulin challenge tests

      hrp0097p1-32
    • Health-Related Quality of Life in Children and Adolescents with Type1 Diabetes Mellitus

      hrp0097p1-33
    • Evaluation of Mitochondrial Bioenergetic Function in Mitochondrial and Type 1 Diabetes

      hrp0097p1-34
    • Effects of insulin therapy on respiratory functions, pulmonary exacerbation and nutritional status in cystic fibrosis-related diabetes

      hrp0097p1-35
    • Incidence of Newly Diagnosed Childhood Diabetes and Severity at Onset Between Pre-Pandemic and Pandemic COVID-19 Eras in Northern Thailand

      hrp0097p1-36
    • Dietary Intake in Children and youth with Type 1 Diabetes from Different Ethnic Backgrounds and its Relation to Different Metabolic Parameters

      hrp0097p1-37
    • Efficacy of faster aspart in insulin pumps in children and adolescents with Type 1 Diabetes Mellitus: A single-center study with real-world data

      hrp0097p1-38
    • Prevalence of Insulin-induced Lipohypertrophy (LD) in children and Adolescents with Type 1 Diabetes Mellitus in relation to important risk factors: Review of literature in the past 15 years in 11 countries

      hrp0097p1-39
    • Neopterin and tryptophan pathways in children with type 1 diabetes: isoxanthopteridine as a marker of endothelial dysfunction

      hrp0097p1-40
    • ADIPOQ gene (adiponectin) causing neonatal diabetes mellitus in a Palestinian newborn

      hrp0097p1-41
    • Type 1 diabetes in the covid pandemic: what changed?

      hrp0097p1-42
    • Our experience in neonatal diabetes mellitus: clinical and molecular characterisation

      hrp0097p1-43
    • New-onset DKA in a child complicated by hypertriglyceridemia and acute pancreatitis

      hrp0097p1-44
    • Common challenges of one uncommon syndrome - single center experience with Congenital Generalized Lipodystrophy

      hrp0097p1-45
    • Associated autoinmmunity in children and adolescents with type 1 diabetes mellitus

      hrp0097p1-46
    • The retrospective/blind glucose monitoring (bCGM) system is valuable tool for hyperglycemic and hypoglycemic states

      hrp0097p1-47
    • Changing Diabetes in Children Indonesia: Public-private partnership to improve healthcare access for children and adolescents with type 1 diabetes mellitus

      hrp0097p1-48
    • Quantiferon test versus Tuberculin test to screen for Latent Tuberculosis in Type 1 diabetic children: a single center experience

      hrp0097p1-49
    • Secondary PREvention of Diabetes Type 1 with oral CALcitriol and analogs, the PRECAL study

      hrp0097p1-228
    • Trajectories of glycemic control in transition-aged patients with type 1 diabetes

      hrp0097p1-229
    • Motivational interviewing from the pediatricians' perspective: assessments after a 2-day training for physicians caring for adolescents with chronic medical conditions (CMCs)

      hrp0097p1-230
    • Children with Type 1 Diabetes and Obesity show biochemical changes associated with insulin resistance

      hrp0097p1-231
    • A Case with Alstrom Syndrome with a Novel Pathogenic Variant In ALMS1 gene as a Rare Cause of Diabetes Mellitus

      hrp0097p1-232
    • Diabetes Behind the Mask

      hrp0097p1-233
    • Health services for children with diabetes mellitus in Dnipro, Ukraine

      hrp0097p1-234
    • Recurrence Risk Of T1DM In First Or Second Degree Relatives: First Indian Report

      hrp0097p1-235
    • The impact of covid-19 pandemic on the incidence type 1 diabetes in children

      hrp0097p1-236
    • Effects of the COVID-19 pandemic on anthropometric data, glycemic control, and lipid levels in children and young people with type 1 diabetes: two years of follow-up

      hrp0097p1-237
    • MiniMed 780G Advanced Hybrid Closed Loop System Outcomes According to Pubertal Status - Awesome Study Group Real-Life Experience

      hrp0097p1-238
    • Epidemiology of Type 1 Diabetes among children under 15 years of age in Navarre (Northern Spain) between 2012-2022

      hrp0097p1-239
    • Age differences in the distribution of diabetes-specific antibodies in children and adolescents with type 1 diabetes mellitus

      hrp0097p1-240
    • Association between osteocalcin and secretory function of islet beta cells in diabetic pediatric population: a pivotal study

      hrp0097p1-241
    • Prevalence of Insulin-induced Lipohypertrophy (LD) in Type 1 Diabetes Mellitus (T1DM): CSII versus MDIT and Children versus adults.: Review of literature in the past 15 years in 10 countries

      hrp0097p1-242
    • A comparison of Quality of Life in Children with Diabetes Type 1 in Cyprus treated with Multiple daily injections of insulin to children utilizing CGM as adjutant to MDI and to children treated with Continuous Subcutaneous Insulin Infusion

      hrp0097p1-243
    • Knowledge of healthcare practitioners before and after paediatric T1DM diagnosis and management training

      hrp0097p1-244
    • Combination of mutations in the HNF1A and ABCC8 genes: clinical polymorphism in members of the same family

      hrp0097p1-245
    • Quality Improvement Initiative to Improve Influenza Vaccination Uptake Rates in Paediatric Patients with Diabetes Mellitus

      hrp0097p1-427
    • Abstract unavailable

      hrp0097p1-428
    • Increased Incidence of New-Onset Type 1 Diabetes and Diabetic Ketoacidosis in Children and Adolescents During Coronavirus Pandemic

      hrp0097p1-429
    • What do they eat? Calculation of carbohydrate, fat and protein intake in children with type 1 diabetes (T1D) by use of an image based analysis by smartphone.

      hrp0097p1-430
    • Telemedicine usefulness in the follow-up of young people with diabetes 1 diabetes 2-years after the spread of COVID-19

      hrp0097p1-431
    • Prevalence of sleep disorders in children and adolescents with type 1 diabetes and its relation to glycemic control: A single center stud

      hrp0097p1-432
    • Effects of triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy on glucose metabolism in cystic fibrosis patients

      hrp0097p1-433
    • Monogenic Diabetes gene variants in 323 Greek MODY patients: Targeted NGS increases diagnostic accuracy and allows identification of rare MODY subtypes

      hrp0097p1-434
    • Management of severe diabetic ketoacidosis with extremely high doses of insulin in a girl with severe insulin resistance syndrome due to compound heterozygous mutations in the insulin receptor gene

      hrp0097p1-435
    • Should the diagnostic criteria of childhood obesity depend on the nutritional status of national pediatric population? A lesson form assessment of Ukrainian children with type 1 diabetes in Poland after Russian aggression against Ukraine

      hrp0097p1-436
    • Efficacy of the Tubeless Insulin Management System on Glycemic Control in Children and Adolescents with Type 1 Diabetes Previously Treated with Multiple Daily Injections and Flash Glucose Monitor Over the First 12 Weeks of Use

      hrp0097p1-437
    • A qualitative study of knowledge, attitudes and perceptions of new diabetes technologies in A&E department

      hrp0097p1-438
    • Determinants And Characteristics Of Insulin Dose Requirements In Children And Adolescent With New-Onset Type 1 Diabetes: Insights From The INSENODIAB Study

      hrp0097p1-439
    • Monogenic forms of neonatal diabetes: our casuistics and evolution

      hrp0097p1-440
    • A Case Series of Two Adolescents with HNF1B MODY and Multisystem Disorders

      hrp0097p1-441
    • Identification of GCK-MODY in case of neonatal hyperglycemia

      hrp0097p1-442
    • To study the prognostic significance of the molecule intercell adhesion type 1 (ICAM1 – intercellularadhesion molecule type 1, CD54) and adhesion moleculesvascular endothelium type 1 (VCAM1 - vascularcell adhesion molecule type 1, CD106) in children with type 1 diabetes mellitus after COVID 19 infection

      hrp0097p1-443
    • From human insulin to insulin analogues: what impact on the BMI of children with type 1 diabetes?

      hrp0097p1-444
  • Fat, Metabolism and Obesity
  • • The Gut Microbiota Profile of Children with Prader–Willi Syndrome in China

      hrp0097p1-50
    • GLP1 agonists improve glycaemic dysregulation, satiety levels and quality of life in adolescents with obesity

      hrp0097p1-51
    • Effects of Relaxation of COVID-19 restriction measurements on glucose and insulin metabolism in overweight and obesity youth

      hrp0097p1-52
    • First results from the ongoing Med4Youth European study: comparing Mediterranean diet with a Low-Fat Diet for adolescents with obesity

      hrp0097p1-53
    • Early corneal nerve fiber regeneration in children with obesity and impaired glucose tolerance treated with the GLP-1 agonist Liraglutide

      hrp0097p1-54
    • Association between serum uric acid and blood pressure in children and adolescents: A systematic review-meta regression

      hrp0097p1-55
    • Lipoma slice cultures as a new model to examine the effects of PI3K inhibitors on lipid accumulation

      hrp0097p1-56
    • Trends in prevalence of overweight, obesity and severe obesity among Norwegian children from 2010 to 2022

      hrp0097p1-57
    • Neck circumference and metabolic score before and after long-term impact of a lifestyle intervention in patients with abdominal obesit

      hrp0097p1-58
    • Diagnostic value of soluble LEPR levels in the serum of patients with disease-causing biallelic LEPR variants

      hrp0097p1-59
    • Clinical usefulness of bioimpedance analysis in children and adolescents with severe obesity. Preliminary results of the Polish-German study project on severe early-onset obesity

      hrp0097p1-60
    • Incidental Sitosterolemia on Genetic testing in Saudi Youth Presenting with Bony lesions, A Case Study

      hrp0097p1-61
    • Effect of metreleptin on metabolic changes in patient with congenital generalized lipodystrophy

      hrp0097p1-62
    • The effectiveness of novel E-Health applications for the management of obesity in childhood and adolescence during the COVID-19 outbreak in Greece

      hrp0097p1-63
    • Abstract unavailable

      hrp0097p1-64
    • Natural history of corpulence in patients carrying heterozygous pathogenic variants in the five major genes of the leptin-melanocortin pathway

      hrp0097p1-65
    • Leptin treatment affects adipose progenitor cells physiology

      hrp0097p1-66
    • Percentage of Appendicular Skeletal Muscle Mass Reference and Association with Metabolic Syndrome in Korean Adolescents

      hrp0097p1-67
    • The association of triglyceride glucose-body mass index with transient elastography in pediatric non-alcoholic fatty liver disease

      hrp0097p1-68
    • Difference of nafld frequency between younger and older children with obesity

      hrp0097p1-69
    • Association of Serum Uric Acid Levels with Metabolic Syndromes in Children and Young Adolescents

      hrp0097p1-70
    • Obesity prevalence and gender incongruence – Results from a systematic literature review

      hrp0097p1-71
    • GLP-1 analogues in therapy of obese adolescents. Early real-life experience with liraglutide treatment

      hrp0097p1-72
    • Insulin as a treatment modality for familial chylomicronemia syndrome in resource-limited settings- A Case series

      hrp0097p1-73
    • A novel mutation of leptin gene in two siblings with early onset obesity

      hrp0097p1-74
    • Newer anthropometric indexes predicting insulin resistance in Greek children and adolescents with overweight and obesity

      hrp0097p1-75
    • Evaluation of Clinical Characteristics of Patients Diagnosed with Syndromic Obesity

      hrp0097p1-76
    • Association between Steroid Therapy and Lipid Profiles in Children with Chronic Disease

      hrp0097p1-77
    • Evaluation of Τri-Ponderal Mass Index as a reflector of adiposity among pediatric cancer survivors

      hrp0097p1-78
    • Features of exogenous-constitutional obesity in children and adolescents of the Uzbek population depending on age

      hrp0097p1-79
    • Leukocyte, platelet counts and the neutrophil-to-lymphocyte ratio (NLR) are related to insulin resistance in obese and overweight children

      hrp0097p1-80
    • Comparison of HbA1c and OGTT for the identification of type 2 diabetes in obese children above 10 years of age

      hrp0097p1-81
    • Leptin receptor’s mutation in a patient with childhood obesity and hyperphagia

      hrp0097p1-82
    • Improvement in Health-Related Quality of Life scores in Children and Young people with Obesity following intervention and support from a Tertiary MDT Weight Management Service

      hrp0097p1-83
    • Obesity Caused by Mutations in the Melanocortin 4 Pathway: Experience From a Teaching Hospital

      hrp0097p1-246
    • Th17 lymphocytes and peripheral complete blood count alterations in obese children

      hrp0097p1-247
    • Single Gene Variations in Etiology in Children with Severe Obesity

      hrp0097p1-248
    • Association of chemokine network profile with albuminuria in obese children

      hrp0097p1-249
    • Sitosterolemia – An underdiagnosed and heterogeneous lipid disorder. A Case Series from The Children’s Hospital at Westmead NSW Australia

      hrp0097p1-250
    • Overweight and obesity in childhood and adolescence is associated with an increased fracture risk - Results of a systematic literature review

      hrp0097p1-251
    • Dietary and physical activity habits of children and adolescents after a personalized intervention for the management of obesity

      hrp0097p1-252
    • Effect of growth hormone on thermogenic and endocrine activity of brown adipose tissue and on the lipidome of children born small for gestational age

      hrp0097p1-253
    • The early identification of glycaemic dysregulation with the use of continuous glucose monitoring in children and young people with obesity

      hrp0097p1-254
    • Comparison of triglyceride-glucose index and HOMA-IR for predicting severity of nonalcoholic fatty liver disease in Korean children and adolescents

      hrp0097p1-255
    • Serum leptin concentrations in a pooled cohort of 6.105 children and adolescents: Reference values as a function of dependence on sex, age, pubertal stage and BMI-SDS

      hrp0097p1-256
    • Risk Factors for becoming adult with obesity in survivors of childhoodcancer

      hrp0097p1-257
    • An interesting case of combined familial hyperlipidaemia and high lipoprotein (a) in a 20-month-old girl

      hrp0097p1-258
    • Exploring the Relationship between Muscle-to-Fat Ratio and Surrogate Markers of Nonalcoholic Fatty Liver Disease in Children with Overweight and Obesity

      hrp0097p1-259
    • Early onset obesity due to Melanocortin 4 receptor (MC4R) defect; Successful treatment with Semaglutide

      hrp0097p1-260
    • Decreased physical fitness in children is associated with increased cardiovascular risk determined by increased carotid intima-media thickness

      hrp0097p1-261
    • 16p11.2 microdeletion: a common copy number variation (CNV) identified in a Portuguese pediatric cohort with syndromic obesity

      hrp0097p1-262
    • Evaluating genotype-phenotype relations in pediatric obesity: a single centre experience

      hrp0097p1-263
    • Implementation of the EOSS-P Risk Scale in children and adolescents living with obesity

      hrp0097p1-264
    • Evaluation of Clinical and Genetic Characteristics of Non-Syndromic Monogenic Obese Patients

      hrp0097p1-265
    • Abdominal fat measured with nutritional ultrasound as a risk screening for non-alcoholic hepatic steatosis (NASH) in obese children

      hrp0097p1-266
    • Seven Years Follow Up of a Child with Familial Chylomicronemia Syndrome: Disease Course and Effectiveness of Gemfibrozil Treatment: Case Report and Literature Review.

      hrp0097p1-267
    • The 2016–2021 Korea National Health and Nutrition Examination Survey for Metabolic Alteration in children and adolescent during the COVID-19 Pandemic

      hrp0097p1-268
    • Impact of bariatric surgery on obesity complications in children and adolescents: Evaluation of a large cohort within a specialized French obesity center

      hrp0097p1-269
    • MC4R deficiency in a portuguese pediatric cohort study

      hrp0097p1-270
    • Investigation of LDL Cholesterol in Children from Seiiku Cohort for Children and Mothers

      hrp0097p1-271
    • Various clinical manifestations found in 3 cases with Progeria syndrome

      hrp0097p1-272
    • Congenital Leptin Receptor deficiency: A Novel LEPR gene mutation (LEPR):c.1752G>A (p.Lys584=) in an Indian family producing severe early onset monogenic obesity

      hrp0097p1-273
    • Breakfast skipping is associated with poor diet quality in children with overweight/obesity

      hrp0097p1-274
    • Child with AR sitosterolemia with no hematological manifestations

      hrp0097p1-275
    • A novel mutation in LPL gene in two Brazilian children with familial chylomicronemia syndrome

      hrp0097p1-276
    • Impact of early-life overweight/obesity trajectory on insulin resistance at age 8: a prospective cohort study

      hrp0097p1-445
    • The evolution of diagnosis and care over time in children with Prader-Willi syndrome, born between 2005 and 2021, included in the French database.

      hrp0097p1-446
    • A comparison of the usefulness of two indices of insulin resistance: IRIHOMA (calculated from fasting glucose and insulin values) and IRIBelfiore (calculated from OGTT results) in diagnosis of metabolic complications and determining indications for possible dietary or pharmacological treatment in children

      hrp0097p1-447
    • The Association between Vitamin D deficiency and Hepatosteatosis in Obese Children and Adolescents. (Underreview in Hormone Research Journal- HRP-2023-1-19)

      hrp0097p1-448
    • Body composition following initiation of daily glucocorticoid in Duchenne Muscular Dystrophy: Identifying the timing of increase of fat mass to introduce intensive weight management strategies

      hrp0097p1-449
    • Longitudinal analysis of CCDC3 methylation in placenta and peripheral blood in school-age children: association with gestational obesity and childhood obesity

      hrp0097p1-450
    • Diagnostic Journey with an 80-gene Panel in Non-syndromic Early-Onset Severe Obesity: Association of Outcomes with Metabolic Status and Hyperphagia

      hrp0097p1-451
    • Single center experience on using Liraglutide in adolescents with obesity +/- Type 2 diabetes

      hrp0097p1-452
    • Echocardiographic assessment of periaortic fat thickness and its relationship to cardiovascular risk factors in children with simple obesity

      hrp0097p1-453
    • Identification of Distinct Metabolic Profiles in Childhood Hypercholesterolemia Using Metabolomics Analysis

      hrp0097p1-454
    • Non-Syndromic Monogenic Obesity and Psychiatric Disorders

      hrp0097p1-455
    • Higher levels of liver enzymes are associated with increased left ventricular mass in apparently healthy children. Potential role of HMW-adiponectin and epicardial fat

      hrp0097p1-456
    • PCSK1 Heterozygous Gene Polymorphisms are Associated with Early Onset Morbid Childhood Class III Obesity Across Diverse Ethnic Groups

      hrp0097p1-457
    • Dietary and physical activity habits in children and adolescents in Greece

      hrp0097p1-458
    • Digestive manifestations are frequent in iPPSD/Pseudohypoparathyroidism

      hrp0097p1-459
    • Improvement of Depressive and Anxiety Symptoms in Children and Adolescents with Overweight and Obesity Following Implementation of a Comprehensive, Multidisciplinary, Personalized, Lifestyle Intervention Program

      hrp0097p1-460
    • Study on the correlation of metabolic syndrome with sex hormone binding protein and testosterone in obese boys

      hrp0097p1-461
    • Determinants of reduced insulin sensitivity in young adults born from preeclamptic pregnancies

      hrp0097p1-462
    • Association between lean mass and metabolic syndrome risk in Korean children and adolescents

      hrp0097p1-463
    • Occurrence of cardiovascular risk factors in Polish children and adolescents with severe obesity. Preliminary results of the Polish-German study project on severe early-onset obesity

      hrp0097p1-464
    • When a pandemic hits another pandemic: the rising overweight and obesity in children in North Macedonia

      hrp0097p1-465
    • The effect of lifestyle intervention on glycaemic variation, quality of life and satiety levels in children and young people with obesity

      hrp0097p1-466
    • Evaluation of concentrations of homocysteine in obese and overweight adolescents and its correlation with lipid and carbohydrate parameters

      hrp0097p1-467
    • Efficacy of zinc and myo-inositol on weight loss and metabolic features in a pediatric population with obesity

      hrp0097p1-468
    • Compound heterozygous SLC5A2-Mutation leading to familial renal glucosuria in an 11-year-old boy

      hrp0097p1-469
    • Evaluation of the Frequency and Time Course of Side Effects Asscociated With Metformin Use In Obese Adolescents As Related to Weight Loss: A Prospective Single-Centre Observational Study

      hrp0097p1-470
    • Life-saving management and therapy in a growth-hormone naive superobese adolescent with Prader-Willi Syndrome: Very low energy diet, GLP-1 analog and nasal oxytocin

      hrp0097p1-471
    • First Case of Familial Partial Lipodystrophy Type 2 (FPLD2) from Kazakhstan Presenting with Life Threatening Arrhythmias and Dilated Cardiomyopathy

      hrp0097p1-472
    • Metabolic Profile of Obese North Macedonian children and adolescents

      hrp0097p1-473
    • Identifying MAFLD and its metabolic risk factors in Polish children and adolescents with severe obesity. Preliminary results of the Polish-German study project on severe early-onset obesity

      hrp0097p1-474
    • A girl with ROHHAD syndrome – a rare cause of rapid-onset obesity and hypothalamic dysfunction

      hrp0097p1-475
    • Complications of excess weight (CEW) seen in tier-3 paediatric weight management services: A two-centre experience

      hrp0097p1-476
  • Fetal, Neonatal Endocrinology and Metabolism
  • • Impact of bariatric surgery on newborn growth parameters

      hrp0097p1-84
    • Associations of eating behavior and metabolic status in young children and variants of energy metabolism genes

      hrp0097p1-85
    • Measurements of Growth Hormone using dried blood spots in preterm neonates: reference values and longitudinal evaluation

      hrp0097p1-86
    • A novel CACNA1D mutation leading to severe diazoxide unresponsive CHI

      hrp0097p1-87
    • The variable outcome of childhood growth in congenital hyperinsulinism

      hrp0097p1-88
    • Maternal, placental and fetal IGF-1/IGFBP in Diabetic pregnancies and their effect on fetal/infantile growth

      hrp0097p1-89
    • Low-Dose Diazoxide Therapy in Hyperinsulinaemic Hypoglycaemia

      hrp0097p1-90
    • Short- and Long-term Outcomes of Diazoxide Unresponsive Infants with Diffuse Hyperinsulinism

      hrp0097p1-91
    • Relationship between birth body weight<10.th centile (sga) and insulin-like growth factor binding protein-3: relevance of birth chest circumference / birth body weight ratio independently of birth gestational age, insulin-like growth factor binding protein-1 and -2 in the not-life threatened newborn

      hrp0097p1-92
    • Incidence and etiology of congenital hyperinsulinism in Slovakia

      hrp0097p1-93
    • Thyroid function in small for gestational age and appropriate for gestational age preterm infants admited to the NICU at Notre Dame Des Secours - University Medical Center

      hrp0097p1-94
    • Severe neonatal hypoglycemia ≤30 mg/dl is associated with adverse neurodevelopment in mid-childhood

      hrp0097p1-277
    • Exploration of O-link protein biomarkers in children born after IUGR and early impaired developmental changes in heart function

      hrp0097p1-278
    • A Year-Long, National Trial of Prospective CGM Use in Families with Hyperinsulinism

      hrp0097p1-279
    • The Metabolism of 11-Oxy Androgens by Fetal CYP3A7 and CYP3A4 is Less Efficient Compared to Classical Androgens

      hrp0097p1-280
    • Steroid secretion and morphological aspects of fetal adrenal before/after freezing/thawing and 14 days in organotypic culture

      hrp0097p1-281
    • Measurement of fetal subcutaneous fat in the diagnosis of fetal macrosomia in pregnancies with diabetes mellitus

      hrp0097p1-282
    • Developing a Collaborative Research Network to Accelerate the Understanding and Treatment of the Rare Disease Congenital Hyperinsulinism

      hrp0097p1-283
    • Neonatal hypoglycemia at one and four hours of life: incidence and associated factors

      hrp0097p1-284
    • Severe Neonatal Donohue Syndrome: Extreme Hyperinsulinemia, Progressive Hypertrophic Cardiomyopathy (HCM) and Failure to Thrive

      hrp0097p1-285
    • Aetiology and Outcome of Hypoglycaemia in Young Children

      hrp0097p1-286
    • Mutations in exon 28 of ABCC8 gene in Egyptian patients with congenital hyperinsulinism

      hrp0097p1-287
    • Newborn screening for Congenital adrenal hyperplasia in Pakistan; Pioneering the way forward

      hrp0097p1-477
    • Whole-exome sequencing results in patients with congenital hyperinsulinism

      hrp0097p1-478
    • Early-life exposure to phthalates and minipuberty: is there any relationship?

      hrp0097p1-479
    • Grb10a Knockdown in Early Life Permanently Alters Growth, Cardiometabolic Phenotype, and the Co-ordination of the Whole Transcriptome in Zebrafish

      hrp0097p1-480
    • Treatment of Transient Hypothyroxinaemia Of Prematurity may improve premature newborns’ neurodevelopment. NEOTHYR, a multicentered retrospective cohort study about 373 subjects

      hrp0097p1-481
    • Human milk short-chain fatty acids promote early myelination in a 2D human co-culture of oligodendrocytes and cortical neurons

      hrp0097p1-482
    • Incidence of Perinatal Stress Hyperinsulinism Requiring Diazoxide Treatment in Newborn Infants

      hrp0097p1-483
    • Relationships between birth body weight<10.th centile (SGA) and insulin-like growth factor-ii / insulin-like growth factor binding protein-3 ratio in the not-life threatened newborn: relevance of birth chest circumference / birth body weight ratio and oxygen supplementation

      hrp0097p1-484
    • A case of a newborn diagnosed with CMAMMA suspected of primary immunodeficiency

      hrp0097p1-485
    • Severe hypercalcemia due to subcutaneous fat necrosis despite minimal skin lesions in a newborn: a case report

      hrp0097p1-486
    • The Association of Maternal Pre-pregnancy BMI and Gestational Weight Gain on the Course of Pregnancy and Some Neonatal Parameters

      hrp0097p1-487
    • Characteristics of the neonatal period in children with Prader-Willi syndrome

      hrp0097p1-488
  • GH and IGFs
  • • Clinical and laboratory characteristics in children with growth hormone deficiency (GHD) and short stature unresponsive to stimulation tests (SUS)

      hrp0097p1-95
    • Modified Insulin Stress Test for Assessment of Growth Hormone Secretion – Experience from a University Teaching Hospital

      hrp0097p1-96
    • Efficacy of long-acting growth hormone preparation in children with growth hormone deficiency

      hrp0097p1-97
    • Evaluation of patients with growth hormone deficiency during the transition period

      hrp0097p1-98
    • Clinicians’ perceptions on ease of use and usefulness of Aluetta^® Smartdot™ and comprehensive digital health ecosystem in Italy to support patients receiving r-hGH treatment

      hrp0097p1-99
    • Exploring healthcare professionals’ attitudes towards digitalization and the perceived usefulness and ease of use of digital solutions in patients receiving growth hormone therapy: Results of a Korean participatory study

      hrp0097p1-100
    • Withdrawing growth hormone treatment at mid-puberty in idiopathic isolated growth hormone deficiency: baseline characteristics in patient-preference design study

      hrp0097p1-101
    • Assessment of clinical pediatric perception of short stature in childhood and challenges to treat with Growth Hormone in Brazil: A exploratory evaluation of a developing country daily practice

      hrp0097p1-102
    • Assessing the treatment burden and Quality of Life of children receiving daily recombinant Growth Hormone treatment in Greece

      hrp0097p1-103
    • Healthcare professionals’ perceptions on the quality and evolution of digital health devices to support paediatric growth hormone therapy: Results of a French participatory study

      hrp0097p1-104
    • Effects of Growth Hormone Therapy on Glucose Metabolism in Children and Adolescents: 1-year follow-up results

      hrp0097p1-105
    • Growth Hormone (GH) Therapy in Children with short stature: A cross-sectional study of indication and treatment outcomes- 12-year single center experience

      hrp0097p1-106
    • The Growth Predictive Value of (IGF1/Growth Hormone Peak) Ratio in Children with Idiopathic Short Stature (ISS)

      hrp0097p1-107
    • A challenging case of Pituitary Gigantism

      hrp0097p1-108
    • The Growzen™ buddy smartphone application shows positive findings on adherence in Argentinian patients receiving growth hormone therapy for growth disorders

      hrp0097p1-288
    • Long-term effectiveness and safety of growth hormone therapy in Japanese children with short stature due to Noonan syndrome (NS): real-world data

      hrp0097p1-289
    • Optimal injection device settings to achieve high adherence to growth hormone treatment in patients with growth disorders

      hrp0097p1-290
    • Adult heights of the cases whose GH treatment was discontinued at early retesting reached their target heights

      hrp0097p1-291
    • Clinical predictors of good/poor response to growth hormone treatment (GHT) in children with idiopathic short stature (ISS)

      hrp0097p1-292
    • Healthcare professionals’ perceptions on the quality and evolution of digital health devices to support paediatric growth hormone therapy: Results of a UK participatory study

      hrp0097p1-293
    • A novel variant of IGF1R in a Chinese family with short stature and efficacy of recombinant human growth hormone therapy

      hrp0097p1-294
    • Sex steroid priming decreases the frequency of divergent results between spontaneous and stimulated GH tests

      hrp0097p1-295
    • The efficacy and safety of rhGH treatment combined with letrozole/GnRHa in adolescent boys

      hrp0097p1-296
    • Evening or morning growth hormone treatment?

      hrp0097p1-297
    • Quality of life at adult height in adolescents and young adults treated by GH

      hrp0097p1-298
    • Real-world adherence to growth hormone treatment and catch-up growth in children with growth disorders in France: An interim analysis from the SCOPE study

      hrp0097p1-299
    • Assessment of the rhGH treatment compliance in children with growth hormone deficiency

      hrp0097p1-300
    • Outcome of growth hormone treatment in growth hormone deficient children over the course of 3 years in Notre Dames Des Secours-University Medical Center Byblos-Lebanon-single center experience

      hrp0097p1-301
    • Influencing Factors on Selection of Initial Treatment Dose in Children Diagnosed with Isolated Growth Hormone Deficiency

      hrp0097p1-302
    • Further analyses on the role of IGF-I in the diagnosis of GH deficiency (GHD) in children

      hrp0097p1-303
    • Prevalence and predictors for growth hormone deficiency in children born small for gestational age with short stature

      hrp0097p1-304
    • A rare case of microduplication 5q35.2-q35.3, also known as anti-Sotos syndrome, in a female patient

      hrp0097p1-305
    • Effects of GH therapy in patients with GHD (Growth Hormone Deficiency) on glucose homeostasis: results of a 10-years follow-up

      hrp0097p1-489
    • Phenotype and genotype of children with biallelic GHRHR gene mutations: a Belgian case series

      hrp0097p1-490
    • Priming with sex steroids increases the specificity of GH tests in the diagnosis of “True” isolated growth hormone deficiency

      hrp0097p1-491
    • GH stimulation testing: is it time to change the paradigm?

      hrp0097p1-492
    • Use of aromatase inhibitors in short children and adolescents to optimize final height: A current practice survey

      hrp0097p1-493
    • Comparison of insulin tolerance test and arginine test in the diagnosis of growth hormone deficiency in children

      hrp0097p1-494
    • Difficulties in interpreting insulin-like growth factor 1 (IGF-1) levels in short stature children born small for gestational age (SGA) treated with recombinant human growth hormone (rhGH) based on data from six clinical centres in Poland

      hrp0097p1-495
    • Comparative Efficacy of Growth Hormone treatment on children with Idiopathic Growth Hormone Deficiency (and Idiopathic Short Stature (A 12year Tertiary Center Experience

      hrp0097p1-496
    • First-year response to growth hormone (rGH) treatment and assessment of iGRO software for the prediction of growth velocity

      hrp0097p1-497
    • The relationship between body mass index and therapeutic effect in children with idiopathic growth hormone deficiency

      hrp0097p1-498
    • Growth characteristics and final height in survivors of childhood medulloblastoma

      hrp0097p1-499
    • Factors influencing response to growth hormone therapy in patients with growth hormone deficiency

      hrp0097p1-500
    • The Predictive Value of using IGF1/Growth Hormone Peak Ratio on growth parameters in Children with Growth Hormone Deficiency (GHD) before and after GH treatment

      hrp0097p1-501
    • Integration of Nurse-Led Virtual Reviews with Growth Hormone Device-Linked Adherence: a mixed methods, feasibility study

      hrp0097p1-502
    • Risk factors and best predictor of Osteopenia in preterm Neonates: single center experience

      hrp0097p1-503
    • The pattern of growth in a girl with short stature and duplication at 5q35.2q35.3 encompassing NSD1

      hrp0097p1-504
  • Growth and Syndromes
  • • Unique proteomic signatures of Noonan Syndrome-associated LZTR1 variants detected by phosphopeptide analysis

      hrp0097p1-109
    • Comparison of long-term height outcomes in pediatric patients with growth hormone deficiency receiving once weekly somatrogon with those of matched patients treated with once-daily somatropin in the Kabi/Pfizer International Growth Study (KIGS)

      hrp0097p1-110
    • The phenotypic spectrum of Kenny-Caffey type 2: a case series and literature review

      hrp0097p1-111
    • Treatment of Short Stature in Aggrecan Deficient Patients with Recombinant Human Growth Hormone: Three-Year Growth Response

      hrp0097p1-112
    • Etiology of extreme tall stature and auxological cues at presentation

      hrp0097p1-113
    • Sex-dimorphic associations of the Prader-Willi imprinted domain with prenatal and postnatal growth in healthy infants

      hrp0097p1-114
    • How are gestational age and size at birth related to pubertal timing and adult height? - Results from the GrowUp Gothenburg studies

      hrp0097p1-115
    • Phenotypic differences in Noonan syndrome based on PTPN11 mutation status

      hrp0097p1-116
    • Evaluating the Beneficial Role of Nutritional Intervention (NI) Trials in Improving Growth in Children with Beta Thalassemia Major (BTM)

      hrp0097p1-117
    • The effect of growth hormone therapy on body composition in girls with Turner syndrome – a 10-year follow-up

      hrp0097p1-118
    • Clinical features and response to rhGH treatment in ten patients with heterozygous IGF1 variants

      hrp0097p1-119
    • Personalized behavioral change technique intervention with TUITEK^® patient support program to support caregivers of children treated with growth hormone in Korea

      hrp0097p1-120
    • First year reponse to growth hormone (GH) therapy is related to long term outcome in GH deficiency (GHD) but not in children born small for gestational age (SGA)

      hrp0097p1-121
    • Near Adult Height in a 14-year-old boy with ACAN Deficiency treated with Growth hormone and Anastrozole

      hrp0097p1-122
    • Aromatase Inhibitors May Increase the Risk of Cardiometabolic Complications in Adolescent Boys

      hrp0097p1-123
    • Caloric intake of 6 months-12 years old children with Prader Willi Syndrome under growth hormone treatment at a reference center

      hrp0097p1-124
    • Significant Linear Growth Impairment in a carrier of an interstitial deletion of *356-kb within cytogenetic band 22q11.21 with good response to growth hormone therapy

      hrp0097p1-125
    • A Rare Coexistence of Turner Syndrome and Mycosis Fungoides: A Case Report

      hrp0097p1-126
    • Effects and safety of growth hormone (GH) treatment in 6 children with pycnodysostosis

      hrp0097p1-127
    • Delayed puberty as a core feature of POLE1: The Irish Experience

      hrp0097p1-128
    • Qatar population-specific centile charts of placental weight to birth weight (PW/BW) ratio in 80 722 newborns born between the 37 th and 42 nd Weeks of Gestation: Relation to Gestational Age, and Gender

      hrp0097p1-129
    • The differences of clinical characteristics and effect of growth hormone treatment according to karyotype classification in Turner syndrome patients

      hrp0097p1-130
    • Perinatal features of children with Silver-Russell syndrome due to 11p15 loss of methylation

      hrp0097p1-131
    • One-year growth response and cost-effectiveness to Human recombinant growth hormone in girls with Turner Syndrome: Results from a large Egyptian retrospective study

      hrp0097p1-132
    • A case of Noonan's syndrome and Combined Pituitary Hormone Deficiency: a new potential association?

      hrp0097p1-133
    • Annual Hearing Screening in Children with Achondroplasia: Results from the First 4 Years in Glasgow

      hrp0097p1-306
    • A unique combination of Klinefelter syndrome and Three M Syndrome in a boy with short stature

      hrp0097p1-307
    • Birth Size and Postnatal Growth in Infants with Solitary Kidney: Does the disease affect Growth?

      hrp0097p1-308
    • Molecular and phenotypic spectrum of cardio-facio-cutaneous syndrome in Chinese patients

      hrp0097p1-309
    • Persistence to growth hormone treatment and clinical characteristics of paediatric patients with growth hormone deficiency: A retrospective database study

      hrp0097p1-310
    • Management of rhGH treatment in children with CKD in current clinical practice: a multicentric study

      hrp0097p1-311
    • Associations between weight-related anthropometric measurements and occurrence of breast development, pubic hair and menarche

      hrp0097p1-312
    • Genetic aetiology of short stature in children from consanguineous families from Kurdistan, Iraq

      hrp0097p1-313
    • A case report of Noonan-like syndrome and refractory treatment for increasing growth

      hrp0097p1-314
    • Which Method is More Effective in Predicting Adult Height in Pubertal Girls Treated with Gonadotropin-Releasing Hormone Agonist?

      hrp0097p1-315
    • The effects of androgen treatment on growth in patients with 5-α-Reductase type 2 deficiency

      hrp0097p1-316
    • Growth hormone treatment in a case of Melnick-Needles Syndrome

      hrp0097p1-317
    • 15-year experience with the IGF1 generation test in the Netherlands

      hrp0097p1-318
    • Progressively impaired prepubertal growth in children with APECED

      hrp0097p1-319
    • Achondroplasia: a novel deep intronic variant of the FGFR3 gene, c.1075 + 95C>G, disrupts mRNA splicing

      hrp0097p1-320
    • Questionnaire concerning the process of puberty induction among patients with Turner Syndrome

      hrp0097p1-321
    • Postnatal Linear Growth Among Very Low Birthweight Infants (<1.5kg) in the first 2 years of life

      hrp0097p1-322
    • A systematic review of core outcomes reported in clinical trials of growth hormone therapy in children with growth hormone deficiency

      hrp0097p1-323
    • PROGRES, a multi-country, non-interventional, prospective study of patients receiving human growth hormone treatment under routine clinical care: Study update

      hrp0097p1-324
    • Clinical and Genetic Analysis of Ten Short Stature Patients with ACAN Variants

      hrp0097p1-325
    • Sex Non-Specific Growth Charts and Potential Clinical Implications in the Care of Transgender Youth and Rare Disease Populations

      hrp0097p1-326
    • Growth results after GH treatment of children with juvenile idiopathic arthritis

      hrp0097p1-327
    • CEP57 variant associated with MVA2 syndrome in two Moroccan brothers

      hrp0097p1-328
    • Long-term (9-year, 8-year and 3.5-year) follow-up of treatment with rhGH in three patients with Noonan syndrome due to PTPN11 mutation and confirmed growth hormone deficiency

      hrp0097p1-329
    • A complex phenotype due to the overlap of two rare conditions: miller-mckusick-malvaux (3M) and chung-jansen syndrome

      hrp0097p1-330
    • Changes in carbohydrate and lipid metabolism during 10-year follow-up of patients with Turner syndrome treated with growth hormone

      hrp0097p1-505
    • Characteristics, effectiveness and safety data for patients with growth failure treated with recombinant IGF-1 and achieving adult or near-adult height: results from the Increlex^® Global Registry

      hrp0097p1-506
    • Identification and characterisation of novel HMGA2 variants expand the clinical spectrum of Silver-Russell syndrome

      hrp0097p1-507
    • Placental measurements in relation to gestational age (GA) and fetal growth Characteristics (SGA, AGA and LGA) in a large Cohort in Qatar(n= 80722)

      hrp0097p1-508
    • Significant height response to growth hormone treatment in subjects with Wiedemann Steinert syndrome

      hrp0097p1-509
    • Tuberous sclerosis complex 1 (TSC1) deficiency leads to increased proliferation of adipose progenitor cells – case report and in vitro studies

      hrp0097p1-510
    • Pathway to assess severe primary IGF-1 deficiency diagnosis by using the IGF-1 generation test in a real-life setting: data from the Global Increlex^® Registry

      hrp0097p1-511
    • Growth and final height of adolescents with systemic juvenile idiopathic arthritis in the transitional age: a monocentric case series

      hrp0097p1-512
    • Efficacy of Once-Weekly Treatment for Paediatric Growth Hormone Deficiency: A Systematic Literature Review and Indirect Treatment Comparison

      hrp0097p1-513
    • Addition of genetic workup in children with isolated short stature to improve the diagnostic yield for growth hormone treatment

      hrp0097p1-514
    • Two novel cases of CHOPS syndrome support the evidence of a highly homogeneous phenotype including short stature with skeletal abnormalities and obesity

      hrp0097p1-515
    • Analysis of Pubertal Height Gain after Menarchal girls in Korea

      hrp0097p1-516
    • Bridging the gap between short stature and metabolic alterations in children born small for gestational age: an exploratory study

      hrp0097p1-517
    • Outcomes of growth hormone treatment in children with Prader Willi Syndrome over a 30-year period at the Children’s Hospital at Westmead, New South Wales Australia

      hrp0097p1-518
    • Evaluation of Cognitive Profiles in a cohort of patients with Turner Syndrome

      hrp0097p1-519
    • Does cervical medullary decompression have an impact on growth in children with achondroplasia?

      hrp0097p1-520
    • A variant of uncertain significance in HMGA2 gene, in a 2-year-old child with Silver Russel syndrome like phenotype - a case report

      hrp0097p1-521
    • ACAN gene mutation in a patient born small for gestational age with familial short stature

      hrp0097p1-522
    • A rare occurrence of non-classic congenital adrenal hyperplasia and type 1 diabetes mellitus in a girl with Prader-Willi Syndrome: Case report and review of the literature

      hrp0097p1-523
    • Two male siblings with extremely tall stature, moderate mental retardation and a deletion of ASH1L at chromosome 1q22

      hrp0097p1-524
    • Human milk insulin-like growth factor-1 (HMIGF1) and its effects on Infantile and Childhood Growth

      hrp0097p1-525
    • The first description of neonatal progeroid syndrome (Wiedemann-Rautenstrauch syndrome)in the Russian Federation

      hrp0097p1-526
    • Application of next-generation sequencing in patients suspected of having skeletal dysplasia

      hrp0097p1-527
    • Seasonality in growth of preschool children in Palestine, a pilot study

      hrp0097p1-528
    • A Rare Cause of Pathological Tall Stature: Luscan Lumish Syndrome

      hrp0097p1-529
  • Multisystem Endocrine Disorders
  • • Molecular and Phenotypic Expansion of Bardet-biedl Syndrome in Chinese Patients

      hrp0097p1-134
    • A novel heterozygous variant of FOXJ1 in a Chinese female with primary ciliary dyskinesia and hydrocephalus: A case report and literature review

      hrp0097p1-135
    • Endocrinopathies in Congenital Disorder of Glycosylation (CDG): Short stature and hypergonadotropic hypogonadism are the main endocrinological manifestations in two unrelated cases of PMM2-CDG

      hrp0097p1-136
    • Hypercalcitoninaemia in girl with pseudohypoparathyroidism type 1A

      hrp0097p1-137
    • An isolated hyperchlorhidrosis in a a patient with CA12 mutation

      hrp0097p1-138
    • Endocrine disorders in Inborn Errors of Immunity

      hrp0097p1-139
    • Childhood cancer survivors endocrine late effects: one year retrospective observational study

      hrp0097p1-140
    • Bilateral adrenalectomy for Cushings syndrome in Infantile McCune Albright Syndrome(MAS)-A Case Report

      hrp0097p1-141
    • A patient with multi-locus imprinting disturbance and 46, XY hypovirilization

      hrp0097p1-331
    • Results from learner’s feedback on the use of free, globally accessible CME-accredited e-learning modules in Paediatric Endocrinology and Diabetes

      hrp0097p1-332
    • Case Report: Carney Complex presenting as Bilateral Large Cell Calcifying Sertoli Cell Tumours Treated with Anastrozole

      hrp0097p1-333
    • Gut microbiota, a potential cause of higher insulin sensitivity in children with Prader-Willi syndrome

      hrp0097p1-334
    • High yield of genetic testing in various endocrine disorders

      hrp0097p1-335
    • Clinical presentation and incidence trends of paediatric endocrine conditions at a tertiary referral and teaching hospital, Nairobi, Kenya. a 14 year retrospective study from 2008 to 2021

      hrp0097p1-336
    • Occurrence of central hypothyroidism in children with isolated growth hormone deficiency

      hrp0097p1-337
    • Long-term endocrine sequelae after hematopoietic stem cell transplantation in children and adolescents

      hrp0097p1-338
    • Gastroenterological pathology in 7 patients with autoimmune polyglandular syndrome type 1

      hrp0097p1-339
    • Long-Term Endocrine Complications of Medulloblastoma and The Effect of Growth Hormone Therapy on Final Height

      hrp0097p1-340
    • Anthropometric, clinical, and molecular genetic characteristics of 42 patients with RASopathies

      hrp0097p1-530
    • Clinical analysis of 193 patients with McCune-Albright syndrome in China based on literature review

      hrp0097p1-531
    • Prevalence of endocrinopathies in a cohort of patients with Rett syndrome: a double center observational study

      hrp0097p1-532
    • Utilizing ESPE e-learning to educate Pediatric Endocrinologists in Indonesia: Web-Series on Pediatric Endocrinology and Diabetes (WeSPED), an initiative of the European Society for Paediatric Endocrinology (ESPE) e-learning committee and the Indonesian Pediatric Society (Ikatan Dokter Anak Indonesia-IDAI).

      hrp0097p1-533
    • Endocrinal Disorders in Patients with Chronic Lung Diseases, Single-Center Experience

      hrp0097p1-534
    • An unusual case of secondary amenorrhea in an adolescent.

      hrp0097p1-535
    • Development and implementation of a Pediatric Endocrinology Education Program in Francophone Africa(In French: Programme de formation en Endocrinologie et Diabètologie Pédiatrique pour l’Afrique subsaharienne Francophone [PEDAF])

      hrp0097p1-536
    • Effects of seasonal variability of insolation and COVID-19 pandemic isolation on vitamin D concentrations in children

      hrp0097p1-537
    • Endocrine Late Effects In Survival Children With High-Risk Neuroblastoma From Italian Tertiary Hospital

      hrp0097p1-538
    • Long Term Effects of Pediatric Hematopoietic Stem Cell Transplant on Endocrine Function

      hrp0097p1-539
  • Pituitary, Neuroendocrinology and Puberty
  • • Stimulated copeptin based diagnosis of central diabetes insipidus in children and adolescents

      hrp0097p1-142
    • Comparison of the Test Accuracy of a Subcutaneous Gonadotropin-Releasing Hormone Agonist (Triptorelin Acetate) vs. Intravenous Gonadorelin in the Diagnosis of Central Precocious Puberty

      hrp0097p1-143
    • Idiopathic Central Precocious Puberty on the Rise: A Retrospective Study Before and During the COVID-19 Pandemic in a Portuguese Tertiary-Level Hospital

      hrp0097p1-144
    • Novel clinical and imaging tools to identify and grade hypothalamic disease in populations at risk

      hrp0097p1-145
    • Evaluation of pubertal suppression in adolescents with gender dysphoria in different Tanner stadia

      hrp0097p1-146
    • Quantification of overnight urinary gonadotropin excretion predicts imminent puberty in girls: a semi-longitudinal study

      hrp0097p1-147
    • Prevalence of brain alterations in boys with isolated central precocious puberty

      hrp0097p1-148
    • Evaluation of new cutt-off points of the LHRH stimulation test in the diagnosis of central precocious puberty

      hrp0097p1-149
    • Comparative of serum estradiol levels in girls with different types of precocious puberty by liquid chromatography tandem-mass spectrometry and chemiluminescence immunoassay method

      hrp0097p1-150
    • Clinical profile of children with central precocious puberty in a single tertiary centre

      hrp0097p1-151
    • The awakening of the hypothalamic-pituitary-gonadal axis in the post-COVID era; the Greek experience

      hrp0097p1-152
    • Precocious puberty: a new score to assist therapeutic management

      hrp0097p1-153
    • Central Precocious Puberty in Boys; Diagnosis, Treatment and Follow-up: A Nation-Wide Study

      hrp0097p1-154
    • The long-term efficacy of triptorelin 3-month depot in girls with central precocious puberty

      hrp0097p1-155
    • A novel ROBO1 gene variant in a patient with pituitary stalk interruption and multiple congenital anomalies

      hrp0097p1-156
    • Girls born small for gestational age may have an earlier pubertal development comparing to girls born appropriate for gestational age

      hrp0097p1-157
    • Outcome of Children with Neurofibromatosis in the West of Scotland

      hrp0097p1-158
    • Long-Term Effect of Gonadotropin-Releasing Hormone Analogue Therapy on Adult Height in Girls with Central Precocious Puberty Diagnosed before 4 Years of Age

      hrp0097p1-159
    • COX deficiency: undescribed endocrinological features in three patients with SCO1 mutation

      hrp0097p1-160
    • Quality of life domains changes in children with central precocious puberty

      hrp0097p1-161
    • The Therapeutic Effect of Oral Desmopressin Lyophilisate Formulation in Children with Central Diabetes Insipidus

      hrp0097p1-162
    • Identification of novel NFKB2 mutation in a Korean boy presenting with muscle weakness

      hrp0097p1-163
    • Insight into Gut Microbiota of Normal Body Mass Index Girls with Idiopathic Precocious Puberty

      hrp0097p1-164
    • Pheochromocytoma and it's cardiovascular complications in children.

      hrp0097p1-165
    • Correlation Analysis of Genotypes and Phenotypes of 91 young male paediatric patients with congenital hypogonadotropic hypogonadism

      hrp0097p1-341
    • The relationship between the amount of ghrelin-positive cells in the stomach and the concentration of ghrelin and anti-ghrelin antibodies in the blood in short stature children, with additional analysis of the impact of H. pylori infection

      hrp0097p1-342
    • Facilitating Transition of Care Into Adulthood in Brain Cancer Survivors With Acquired Pediatric Growth Hormone Deficiency: Insights From an Advisory Board

      hrp0097p1-343
    • Neurobehavioural impairments in children with septo-optic dysplasia spectrum conditions: A systematic review

      hrp0097p1-344
    • 45 mg Subcutaneous Leuprolide Acetate Suppressed Unstimulated Luteinizing Hormone (LH) to Prepubertal Concentrations

      hrp0097p1-345
    • Does premature adrenarche affect adult height in girls?

      hrp0097p1-346
    • Treatment of Children with Central Precocious Puberty (CPP) with Gonadotropin-Releasing Hormone agonist (GnRHa): Evaluation of The Effectiveness of Treatment and Recovery of Gonadal Function

      hrp0097p1-347
    • Clinical course and genetic analysis in patients with childhood-onset congenital combined pituitary hormone deficiency

      hrp0097p1-348
    • Compound heterozygous variants in ROBO1 gene cause CPHD and middle line defects

      hrp0097p1-349
    • Onset of puberty and timing of menarche in Saudi schoolgirls: Riyadh Puberty Study II

      hrp0097p1-350
    • Kallmann syndrome as a manifestion of tubulinopathies - a boy with newly defined TUBB3 R262H syndrome

      hrp0097p1-351
    • The incidence of central precocious puberty in Korea between 2012 and 2020, population-based study

      hrp0097p1-352
    • Clinical features of hyperprolactinemia in children and adolescents

      hrp0097p1-353
    • The effect of leuprolide acetate 11.25mg 3-month formulation in children with central precocious puberty: A systematic review and meta-analysis

      hrp0097p1-354
    • Effects of probiotic supplementation during childhood on the gut microbiota when puberty onset in lactating female mice

      hrp0097p1-355
    • Acquired Hypothalamic dysfunction in childhood: “What do patients need?“ – an Endo-ERN survey

      hrp0097p1-356
    • Evaluation of the pituitary gland in patients with Fanconi Anemia

      hrp0097p1-357
    • Do gonadotropin releasing hormone analogues increase the total body fat mass and body mass index in girls with idiopathic central precocious puberty?

      hrp0097p1-358
    • An Evaluation of coping strategies in girls diagnosed of central precocious puberty before and after the COVID-19 lockdown, and in their mothers: preliminary study

      hrp0097p1-359
    • Management of central diabetes insipidus in disabled children with diluted oral desmopressin lyophilisate formulation administered through nasogastric tube

      hrp0097p1-360
    • First interim analysis of the value of First Morning Voided（FMV）Urinary GnRH for the Diagnosis in China CPP Patients

      hrp0097p1-361
    • Case Report: rare case of genetic neurohypophyseal diabetes insipidus associated with congenital hypopituitarism: when the fluid deprivation test does not make the diagnosis

      hrp0097p1-362
    • Xanthomatous hypophysitis: A rare cause of paediatric hypopituitarism

      hrp0097p1-363
    • Transient diencephalic syndrome as a result of hypothalamic compression in a paediatric case of neurofibromatosis Type 1 (NF1)

      hrp0097p1-364
    • Central precocious puberty in boys: clinical decision-making and secular trend

      hrp0097p1-540
    • Prediction of Adult Height Based on Automated Bone Age Estimation in Early Puberty: A Single-Center Prospective Study

      hrp0097p1-541
    • Comparation between syndromic and non-syndromic central precocious puberty: a 10-year experience

      hrp0097p1-542
    • Phenotype and genotype in patients with growth hormone difenciency and pituitary morfology abnormality

      hrp0097p1-543
    • Clinical and laboratory characteristics of arginine vasopressin resistance and high carrier frequency of a novel homozygous variant p.R113C in the AQP2 gene among Buryats

      hrp0097p1-544
    • Challenges in Diagnosing and Managing Paediatric Metastatic Paraganglioma: A Case Report

      hrp0097p1-545
    • SEMA3A gene variant may cause situs inversus, incomplete cleft palate, and congenital pituitary hormone deficiency

      hrp0097p1-546
    • Evaluation of Electrocardiographic Changes in Girls Receiving Gonadotropin-Releasing Hormone Analogs for Central Precocious Puberty

      hrp0097p1-547
    • Evaluation Of Long-term Height and Pubertal Outcome Of Boys Presented With Delayed Puberty Due To Constitutional Delay In Growth And Puberty And Isolated Hypogonadotropic Hypogonadism.

      hrp0097p1-548
    • Single nucleotide polymorphisms (SNPs) of the LIN28B gene and age at menarche in a sample of Greek girls

      hrp0097p1-549
    • The endocrine phenotype of SWI/SNF-associated Coffin-Siris syndrome includes pituitary endocrinopathies, pituitary hypoplasia, and septo-optic dysplasia

      hrp0097p1-550
    • Alteration of sex steroid levels in boys with pubertal gynecomastia

      hrp0097p1-551
    • What girls know about puberty?

      hrp0097p1-552
    • A 12-month, open-label, single-arm, phase 3 trial of the efficacy and safety of triptorelin 3-month formulation in Chinese children with central precocious puberty (CPP)

      hrp0097p1-553
    • The Evaluation of Cranial Magnetic Resonance Images of Rapidly Progressive Early Puberty Cases

      hrp0097p1-554
    • Genetic bases of familial central precocious puberty

      hrp0097p1-555
    • Oxytocin Improved Neurobehavioural Dysfunction in an Adolescent Post-Craniopharyngioma Surgery: A case report

      hrp0097p1-556
    • Novel LHX4 rare variant in three patients affected by congenital hypopituitarism, presenting a further co-occurrent desease causing variants in GLI2 and IGF1R

      hrp0097p1-557
    • Do perinatal history and mode of delivery affect age at menarche? Preliminary data of girls with Greek origin

      hrp0097p1-558
    • Longitudinal psychological and behavioral assessments in girls with precocious puberty

      hrp0097p1-559
    • The Difference in Newly diagnosed Precocious Puberty Before and During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis

      hrp0097p1-560
    • Copeptin as a reliable marker in differentiating Nephrogenic Diabetes Insipidus (NDI) and Central Diabetes Insipidus (CDI)-a case study

      hrp0097p1-561
    • Concurrent premature gonadotrophic activation and gonadal insufficiency in young girls with a brain tumor

      hrp0097p1-562
    • Clinical and analytical presentation of central precocious puberty according to age: a 20-year retrospective study

      hrp0097p1-563
    • A case of Klinefelter Syndrome and peripheral precocious puberty

      hrp0097p1-564
  • Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology
  • • Treatment with triptorelin and estradiol in transgender girls. should we use SDS for assigned sex or SDS for affirmed gender?

      hrp0097p1-166
    • Low-dose pioglitazone for polycystic ovary syndrome in adolescent girls:differential fat-mass redistribution by HOTAIR rs1443512 genotype

      hrp0097p1-167
    • Parental perceptions and concerns in a cohort of infants with unoperated hypospadias

      hrp0097p1-168
    • RXFP2: validating its role in autosomal recessive bilateral cryptorchidism and a novel association with male infertility

      hrp0097p1-169
    • Explaining variations of menarcheal age by anthropometrical factors - the GrowUp Gothenburg study

      hrp0097p1-170
    • National trends in central precocious puberty, isolated precocious adrenarche and isolated precocious telarche before and during COVID19 pandemic

      hrp0097p1-171
    • Mutation in FAN1 gene causes impaired DNA damage response and Ovarian Dysgenesis

      hrp0097p1-172
    • Magnetic Resonance Imaging (MRI) Findings and Predictive Factors of Gonadal Neoplasia in Complete Androgen Insensitivity Syndrome

      hrp0097p1-173
    • Ovarian Reserve in Children with Juvenile İdiopathic Arthritis Using Biologic Disease-Modifying Anti-Rheumatic Drugs

      hrp0097p1-174
    • The IGF system shows changes in the follicular fluid of women with PCOS

      hrp0097p1-175
    • Mechanism of mutagenesis and phenotype implications of small indels in the Androgen Receptor gene in Androgen Insensitivity Syndrome

      hrp0097p1-176
    • The consistency between Assigned Gender and Individual Gender Identity in Disorder of Sex Development Cases: Long-Term Results from a Single Center

      hrp0097p1-177
    • Inhibin B- a functional marker to screen gonadal function in CAIS patients?

      hrp0097p1-178
    • Clinical characteristics and genetic expansion of 46, XY disorders of sex development children in a Chinese prospective study

      hrp0097p1-179
    • Clinical, radiological and laboratory characteristics of thelarche variant: a retrospective analysis

      hrp0097p1-180
    • Physicians' Knowledge, Experience, and Attitudes Towards Children and Adolescents with Gender Dysphoria/Incongruence in Turkey

      hrp0097p1-181
    • DNA Ligase IV Deficieny Identified in a Patient with Hypergonadotropic Hypogonadism: A Case Report

      hrp0097p1-182
    • Lipid profiles and HbA1c in transgender adolescents after one year of cross-hormone treatment

      hrp0097p1-183
    • Retrospective Analysis of Individuals with Differences in Sex Development (DSD) in a Brazilian Single-Center Study Across the Lifespan

      hrp0097p1-184
    • Atypical genitalia as a new presentation of ectodermal dysplasia: case report

      hrp0097p1-185
    • Etiology, histology and long-term outcome of bilateral testicular regression: a large Belgian series

      hrp0097p1-365
    • Trends in diagnosis and management of children with Differences in Sex Development over three decades– clinical experience of a tertiary care center

      hrp0097p1-366
    • Changes in body composition in transgender adolescents during puberty suppression and hormone treatment

      hrp0097p1-367
    • Results of Empower-DSD: a patient education programme for children, adolescents, and young adults with differences of sex development (DSD) and their parents

      hrp0097p1-368
    • Abstract unavailable

      hrp0097p1-369
    • Growth and final height in Danish transgender adolescents treated with hormone therapy before cessation of puberty and growth spurt

      hrp0097p1-370
    • Effect of maternal diet on pubertal stages and ano-genital distance from birth up to 12 months: data from the European LIFE-MILCH project

      hrp0097p1-371
    • Incidence of differences of sex development in Switzerland 2000-2019

      hrp0097p1-372
    • Methodological considerations on determining sex steroids in children: Comparison of conventional immunoassays with LC-MS/MS

      hrp0097p1-373
    • Metabolic health status and cortisol metabolism of adolescents with gender incongruence / gender dysphoria during process of diagnosis

      hrp0097p1-374
    • Value of serum AMH and INHB in the diagnosis and treatment of central precocious puberty and early and fast puberty girls

      hrp0097p1-375
    • Obtaining clear birth certificates for children with difference in sex development (DSD) undergoing sex reassignment: A new legal process for Sri Lanka

      hrp0097p1-376
    • Prognostic Factors and Long-Term Safety of GnRHa in the Treatment of Idiopathic Central Precocious Puberty in Girls

      hrp0097p1-377
    • Infant with 45, XO DSD presented with Li Fraumeni syndrome, a case report from Kuwait

      hrp0097p1-378
    • Hyperandrogenism in adolescents assigned female at birth during process of gender incongruence/ gender dysphoria diagnosis

      hrp0097p1-379
    • A novel mutation of androgen receptor in a patient with complete androgen insensitivity syndrome

      hrp0097p1-380
    • The impact of Covid-19 pandemic on incidence of precocious puberty. A comparative study in pediatric population of Northwest Greece and Crete

      hrp0097p1-381
    • A new GATA-4 mutation in a child with disorder of sex development and central precocious puberty

      hrp0097p1-382
    • Insights into pubertal development among individuals with NR5A1/SF-1 variants: Results from the international SF1next study

      hrp0097p1-565
    • Inhibin A (INHA) and steroidogenic factor 1 (SF-1/NR5A1) collaborate in regulating human sex development

      hrp0097p1-566
    • An International Delphi Based Study For Developing A Core Outcome Set For Hypospadias Surgery

      hrp0097p1-567
    • Impact of unilateral ovariectomy on ovarian function and pubertal development in girls with Turner syndrome

      hrp0097p1-568
    • National service evaluation project analysing the quality of care for children and young people with congenital adrenal hyperplasia in the United Kingdom: Data from patients and clinicians

      hrp0097p1-569
    • Elucidating The Genetic Basis of Human Disorders of Sex Development Using Clinic-To-Bench Approach

      hrp0097p1-570
    • Early and long-term gender-affirming treatment does not alter final height in transgender youth

      hrp0097p1-571
    • Prospective Surveillance Of Gonadectomy In DSD – An I-DSD Care Quality Improvement Project

      hrp0097p1-572
    • Testosterone therapy in Duchenne Muscular Dystrophy and longitudinal bone growth with metacarpophalangeal index

      hrp0097p1-573
    • Gonadal histopathology in 17beta-HSD deficiency and 5alpha-reductase deficiency

      hrp0097p1-574
    • Gender-Dysphoric Austrian Youth Seeking Gender Affirming Hormonal Therapy: Baseline Somatic and Psychosocial Health, Gender Affirming Treatment Trajectories and Fertility Preservation Rates

      hrp0097p1-575
    • Transition from Paediatric to Adult Care in Differences of Sex Development (DSD) – Results from the German Network “DSDCare”

      hrp0097p1-576
    • High carrier frequency of a splicing c.589G>A variant in the SRD5A2 gene among Buryats

      hrp0097p1-577
    • Klinefelter Syndrome and Fertility - Current practice in a tertiary Children’s Hospital

      hrp0097p1-578
    • Comparison between clinical, metabolic and hormonal parameters in adolescent girls with hyperandrogenism and healthy controls

      hrp0097p1-579
    • Characteristics and Hormonal Use Patterns among Transgender Female Youth in Thailand: Findings from a Community-Based Survey

      hrp0097p1-580
    • A dual centre evaluation of discontinuation of testosterone therapy in boys with Duchenne Muscular Dystrophy

      hrp0097p1-581
    • Coexisting Disorder of Sex Development and Gender Dysphoria: A case report about an individual with Turner syndrome receiving first female and subsequent male hormone replacement therapy

      hrp0097p1-582
  • Thyroid
  • • Comparison of clinical features, therapy, and disease evolution in a population of children and adolescents with Graves' disease and Type 1 Diabetes compared to Graves' disease alone

      hrp0097p1-186
    • Thyroid nodules and differentiated thyroid carcinoma in children and adolescents. Experience of a tertiary pediatric endocrinology center in Greece

      hrp0097p1-187
    • DICER1 Syndrome and pediatric thyroid carcinoma

      hrp0097p1-188
    • Anemia-based Screening for Resistance to Thyroid Hormone Alpha in Children

      hrp0097p1-189
    • Pubertal timing and characterization in children with congenital hypothyroidism: How important is preschool age anthropometry?

      hrp0097p1-190
    • Paediatric Graves’ Disease: Presentation, Treatment and Follow up. A Single Centre Experience from United Kingdom

      hrp0097p1-191
    • Remission in pediatric hyperthyroidism treated with methimazole

      hrp0097p1-192
    • Thyroid hormone resistance syndrome due to a new mutation in the TRHA gene

      hrp0097p1-193
    • Predicting variables associated with transient congenital hypothyroidism

      hrp0097p1-194
    • A rare case of thyroid dyshormonogenesis with high urine iodine excretion

      hrp0097p1-195
    • Clinical Pattern and management attitudes of Paediatric Graves' Disease in Saudi Arabia, A 10-Year Experience

      hrp0097p1-196
    • Effects of methimazole therapy on effector T and B regulatory cells in pediatric patients with Graves' disease

      hrp0097p1-197
    • Graves’ disease in children with Down syndrome

      hrp0097p1-198
    • Investigating the Incidence of Mild Neonatal Hyperthyrotropinaemia, a Multicentre Study

      hrp0097p1-199
    • Clinical and molecular characteristics of 147 patients with primary congenital hypothyroidism: A single-center experience

      hrp0097p1-383
    • A novel X-linked variant [c.1772delG (p.G591fs*20)] in IRS4 in a patient with central hypothyroidism

      hrp0097p1-384
    • Patients with genetic susceptibility syndromes to thyroid cancer in a tertiary hospital

      hrp0097p1-385
    • Very early diagnosis of Monocarboxylate Transporter 8 (MCT8) Deficiency by measuring Free Triiodothyronine (fT3) in Infancy

      hrp0097p1-386
    • Effect of Daily Zinc Supplementation for 12 Weeks on Serum Thyroid Auto-Antibody Levels in Children and Adolescents with Autoimmune Thyroiditis – A Randomized Controlled Trial

      hrp0097p1-387
    • Neutropenia in paediatric Graves disease patients occurs more often under Carbimazole than Methimazole

      hrp0097p1-388
    • Long-term follow-up of congenital hypothyroidism and predictors of permanent congenital hypothyroidism

      hrp0097p1-389
    • Abstract unavailable

      hrp0097p1-390
    • Molecular Genetic Causes In Elevated TSH: Frequency And Genotype-Phenotype Characteristics

      hrp0097p1-391
    • A case series of multinodular goitres associated with tumour predisposition syndromes

      hrp0097p1-392
    • Primary hydatid cyst of the thyroid gland in a Libyan child

      hrp0097p1-393
    • Assessment of five domains of neurodevelopment and growth in congenital hypothyroidism: Serial 6-year follow-up study of 408 patients

      hrp0097p1-394
    • Thyroid Storm with Diabetes Insipidus: Management of A Rare Endocrine Presentation In A Child

      hrp0097p1-395
    • Hyperfunctioning follicular adenoma in a 9-year-old boy with Prader-Willi Syndrome

      hrp0097p1-396
    • Increased frequency of Grave’s Disease during COVID-19 pandemic

      hrp0097p1-397
    • Positive predictive value of dried blood sampling of TSH in diagnosing congenital hypothyroidism in neonates born at a tertiary care hospital

      hrp0097p1-398
    • Was newborn screening for congenital hypothyroidism affected by COVID19 lockdown?

      hrp0097p1-583
    • National multi-center study of reevaluation of thyroid function in premature infants of less than 32 weeks of gestation and/or less than 1500g admitted to neonatal units

      hrp0097p1-584
    • Papillary thyroid carcinoma incidentally discovered in young patients - a case series

      hrp0097p1-585
    • Hyperthyroidism caused by severe bacterial infection

      hrp0097p1-586
    • Analysis of disease types and prognosis of children with nonthyroid illness syndrome

      hrp0097p1-587
    • The effect of gestational Graves’ disease on the mother-infant dyad: a retrospective observational cohort study

      hrp0097p1-588
    • Thyrotropin receptor stimulating antibodies in pediatric patients with Graves’ diseases using ultra-rapid turbo bioassay

      hrp0097p1-589
    • Predictors of permanent and transient congenital hypothyroidism with eutopic thyroid gland

      hrp0097p1-590
    • Health-Related Quality of Life in Patients Diagnosed with Childhood Primary Hyperthyroidism

      hrp0097p1-591
    • Effect of iodinated contrast on the thyroid function in young children

      hrp0097p1-592
    • Congenital malformations in permanent and transient congenital hypothyroidism – prevalence and etiology

      hrp0097p1-593
    • The relation between psychiatric symptoms and quality of life in children with Graves’ Disease

      hrp0097p1-594
    • A Case report of papillary thyroid carcinoma diagnosed at an early age

      hrp0097p1-595
    • Graves Disease - Longer Term Impact on BMI

      hrp0097p1-596
  • Late Breaking
  • • Familial hCG Syndrome in two Chinese Families with elevated hCG level concurrently in blood and cerebrospinal Fluid

      hrp0097lb1
    • Denosumab in the treatment of paediatric hypercalcaemia

      hrp0097lb2
    • Congenital Hyperinsulinism due to ABCC8/KCNJ11 mutations and the long-term outcome - a single center experience

      hrp0097lb3
    • A novel variant in PRKAR1A at the exon-intron border leads to aberrant splicing in patients affected by carney complex

      hrp0097lb4
    • Clinical phenotyping of patients with genetic obesity

      hrp0097lb5
    • A concomitant increase in thinness and weight excess in Brazilian schoolchildren: evaluation from 2010 to 2022

      hrp0097lb6
    • Hypercalcemia in children: experience from a single center

      hrp0097lb7
    • Mutant MCM8 induces apoptosis and S Phase Arrest in Premature Ovarian Insufficiency

      hrp0097lb8
    • Clinical Characteristics and Long-Term Management for Patients with Vitamin D-dependent Rickets Type II: A Retrospective Study in Saudi Arabia

      hrp0097lb9
    • FTO-mediated m6A modification of BDNF enhances GnRH expression during puberty onset via activating PI3K/AKT signaling

      hrp0097lb10
    • Abstract unavailable

      hrp0097lb11
    • Dysregulated adipose tissue expansion and impaired adipogenesis in Prader-Willi syndrome children before obesity-onset

      hrp0097lb12
    • Low-Dose Liraglutide-Induced Acute Kidney Injury and Hepatocellular Disorder in an Adolescent Patient

      hrp0097lb13
    • Prevalence and risk factors of bone problems in children with supratentorial midline Low Grade Glioma

      hrp0097lb14
    • Metabolic Status in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency

      hrp0097lb15
    • Associations Between Serum Levels of Thyroid Function and Per- and Polyfluoroalkyl Compounds Concentrations in Central Precocious Puberty in Girls

      hrp0097lb16
    • The Majority of Children with Pediatric Growth Hormone Deficiency Treated With Lonapegsomatropin for Up To 6 Years Met or Exceeded Average Parental Height SDS: Final Results of enliGHten

      hrp0097lb17
    • A Novel Variant of NR2F2 Associated with Non-syndromic 46,XY DSD

      hrp0097lb18
    • Identification of a novel homozygous mutation in LEPR gene associated with severe early-onset pediatric obesity in two sisters from Central Brazil

      hrp0097lb19
    • Turner Syndrome: Skin, Liver, Eyes, Dental and ENT assessments should be improved

      hrp0097lb20
• Poster Category 2
• • Adrenals and HPA Axis
  • • Glucocorticoid induced adrenal insufficiency evaluated by the low dose short corticotropin test in children

      hrp0097p2-3
    • Newborn screening for 21 OH Congenital adrenal hyperplasia in Italy: a 14 years population study

      hrp0097p2-4
    • Exploring the Experiences of Parents of Children with Congenital Adrenal Hyperplasia: a study in Developing Country

      hrp0097p2-42
    • The genotype-phenotype correlations in patients with 21-hydroxylase deficiency in Henan, China and the relationship between the clinically effective dosage of hydrocortisone and CYP21A2 genotype

      hrp0097p2-76
    • Massive adrenocortical carcinoma with right atrium invasion in a two-year old girl with li fraumeni syndrome – possibility of succesful ressection after neoadjuvant chemotherapy

      hrp0097p2-77
    • Massive adrenocortical carcinoma with right atrium invasion in a two-year old girl with Li Fraumeni syndrome – possibility of succesful ressection after neoadjuvant chemotherapy

      hrp0097p2-78
    • Final Adult Height in Saudi patients with Congenital Adrenal Hyperplasia

      hrp0097p2-79
    • Cortisol and 11-oxygenated androgens in hair samples from children and adolescents with congenital adrenal hyperplasia

      hrp0097p2-80
    • A 6-year-old boy with Duchenne Muscular Dystrophy and acute adrenal insufficiency: a case report

      hrp0097p2-139
    • Testicular Adrenal Rest Tumors (TARTs) as presenting symptom of CAH due to CYP11A1deficiency

      hrp0097p2-140
    • Pediatric Cushing Disease: a single center experience

      hrp0097p2-141
    • A case of Ectopic ACTH in a girl with thymic carcinoid

      hrp0097p2-155
    • Aldosterone deficiency and resistance: The different faces of renal salt loss

      hrp0097p2-156
    • ACTH-independent hypercortisolemia: onset clinical picture in a 10-year-old boy with Carney complex

      hrp0097p2-157
    • Factors Influencing the Final Height of Congenital Adrenal Hyperplasia Patients

      hrp0097p2-160
    • Cushing’s Disease: an Example of Drug Shortage’s Impact in Pediatric Endocrinology

      hrp0097p2-168
    • Von Hippel-Lindau syndrome in a 9-year-old boy

      hrp0097p2-169
    • Severe hypertension with hypokalemia in uncompliance child with CAH: Fludrocortisone a cause of HTN

      hrp0097p2-186
    • Challenges and barriers of choosing the sex in patients with congenital adrenal hyperplasia: a case report

      hrp0097p2-187
    • 7-year-old girl as compound heterozygote of non-classic congenital adrenal hyperplasia

      hrp0097p2-188
    • A rare case of a newborn with congenital adrenal hyperplasia, osteogenesis imperfect and cow’s milk allergy

      hrp0097p2-189
    • Evaluation of two cases with 46,XX and 46,XY karyotypes diagnosed with 17α-hydroxylase deficiency

      hrp0097p2-190
    • Should we routinely assess hypothalamo-pituitary-adrenal axis in pediatric patients with Prader-Willi Syndrome?

      hrp0097p2-191
    • Neonatal CAH screening in patients with rare causes of inherited primary adrenal insufficiency

      hrp0097p2-192
    • Patient with Carney complex syndrome due to PRKAR1A mutation

      hrp0097p2-193
    • Rare Association of 11 Beta Hydroxylase Deficiency and Gitelman Syndrome and Overlapping Symptoms

      hrp0097p2-202
    • A male infant with X- linked congenital adrenal hypoplasia and Xp 21 contiguous gene deletion syndrome- case report

      hrp0097p2-203
    • A rare case of Aldosterone synthase deficiency presenting with Hypertension

      hrp0097p2-212
    • Pseudohypoaldosteronism in congenital anomaly of the kidneys and urinary tract – case presentation

      hrp0097p2-213
    • APECED and COVID 19: Two Case Reports

      hrp0097p2-214
    • Pseudocushing. an exceptional patology in pediatrics

      hrp0097p2-215
    • Non classic congenital adrenal hyperplasia caused by mutations in CYP21A2

      hrp0097p2-216
    • Primary hypoaldosteronism due to aldosterone synthase deficiency in a small for gestational age born infant

      hrp0097p2-217
    • Early manifestation of primary adrenal insufficiency in patients with X-linked adrenoleukodystrophy: clinical cases description

      hrp0097p2-218
    • Osteoporosis as the first sign of Cushing disease - a case report

      hrp0097p2-219
    • A Case of Adrenal Suppression Secondary to Intranasal Betamethasone

      hrp0097p2-220
    • Diabetes insipidus as first manifestation of congenital malformation of the neurocranium

      hrp0097p2-221
  • Bone, Growth Plate and Mineral Metabolism
  • • Primary hyperparathyroidism in a pediatric patient with tuberous sclerosis

      hrp0097p2-51
    • Patient with ABCD syndrome (Abnormal Calcium, Calcinosis, Creatinine in Down syndrome), a rare cause of pediatric hypercalcemia

      hrp0097p2-52
    • Case report of an 18-month child with profound osteopenia, hypotonia, respiratory distress and RSV bronchiolitis, on a background of vitamin D dependent rickets type 1 (VDDRI): Acute management and 6 months follow-up

      hrp0097p2-53
    • Over four generations of adult-form HPP diagnosed from an asymptomatic child with low ALP levels

      hrp0097p2-54
    • Three Years of Burosumab Treatment in a Child with Cutaneous Skeletal Hypophosphatemia Syndrome: A case report

      hrp0097p2-55
    • Mosaic Disorders of FGF23 Excess: A case of Cutaneous Skeletal Hypophosphatemia Syndrome (CSHS) associated with thyroid medullary carcinoma

      hrp0097p2-56
    • Heterozygous mutations in SETD5 are associated with bone fragility

      hrp0097p2-57
    • Kenny Caffey syndrome 2; expanding the clinical spectrum

      hrp0097p2-58
    • Serum levels of carboxylated and undercarboxylated osteocalcin in non-obese children with Prader-Willi syndrome

      hrp0097p2-59
    • Some of the clinical characteristics of osteogenesis imperfecta in children

      hrp0097p2-116
    • Pediatric onset hypophosphatasia: a case report

      hrp0097p2-117
    • Evaluation of the frequency of decreased bone mineral density and the impact of selected auxological and hormonal factors on bone mass among children with endocrine disorders

      hrp0097p2-118
    • A rare case of hypocalcemia: was it better when it got worse?

      hrp0097p2-119
    • Identification of 2 new heterozygous ACAN variants in a 3-years-old boy with short stature who presented with advanced bone age: a case report

      hrp0097p2-120
    • Clinical findings in three Japanese patients with N-acetylneuraminic acid synthetase-congenital disorder of glycosylation (NANS-CDG)

      hrp0097p2-121
    • A Rare Case of Skeletal Dysplasia: Homozygous Mutation in ACAN Gene

      hrp0097p2-122
    • Hypophosphatasia: a pediatric patient treated with asfotase alfa

      hrp0097p2-123
    • Clinical case: a misleading family history

      hrp0097p2-124
    • Unusual presentation of polyostotic fibrous dysplasia in two unrelated patients

      hrp0097p2-125
    • Vitamin D deficiency in pediatric population and influence on PTH levels

      hrp0097p2-170
    • An Infantile Hypophosphatasia with Novel Mutation in ALPL Gene: A Case Report

      hrp0097p2-171
    • Hyperplastic Callus Formation in an Infant with Type I Osteogenesis Imperfecta: A Case Report

      hrp0097p2-172
    • Caval calcium infusion is the best solution for patients with hereditary vitamin D resistant rickets (HVDRR)

      hrp0097p2-173
    • HIgh variability of phenotypic expression of the same genotype in X linked hypophosphatemic rickets (XLH)

      hrp0097p2-174
    • Kenny Caffey Syndrome; a Rare Diagnosis in Saudi Arabia

      hrp0097p2-175
    • A patient-centred and multi-stakeholder co-designed, mixed methods, observational, prospective study protocol: Example of the adolescent experience of treatment for X-linked hypophosphatemia (XLH)

      hrp0097p2-176
    • Diagnostic and Management Challenges in X linked hypophosphatemic rickets: A case series

      hrp0097p2-209
  • Diabetes and Insulin
  • • The effect of COVID-19 pandemic restrictions on the frequency of diabetic ketoacidosis at the time of diagnosis in children with type 1 diabetes

      hrp0097p2-29
    • Long-term follow-up for the first neonatal diabetes mellitus (NDM) due to KCNJ11 gene mutation who were successfully transferred from insulin to oral sulfonylurea in the Arabian Gulf

      hrp0097p2-30
    • The effect of health literacy of caregiver parents of children and adolescents with Type 1 Diabetes on glycemic control

      hrp0097p2-60
    • Non-immune diabetes. A case of rare genetic insulin resistance syndrome: Rabson Mendenhall Syndrome

      hrp0097p2-61
    • Growth patterns according to glycemic control, CGM apply, and diabetic complications in type 1 diabetes mellitus patients

      hrp0097p2-62
    • The importance of genetic testing and the appropriate use of glibenclamide in neonatal diabetes

      hrp0097p2-63
    • Neonatal diabetes mellitus in a patient with a novel heterozygous mutation in GATA6

      hrp0097p2-64
    • Systematic review on the effects of the COVID-19 pandemic on incidence of new-onset type 1 diabetes (TID), and glycemic control among children/ adolescents with pre-existing TID

      hrp0097p2-65
    • Physician and Family Awareness in the Diagnostic Process of Newly Diagnosed Type-1 Diabetes Mellitus

      hrp0097p2-66
    • Relationship Between Time in Range (TIR), Time Below Range (TBR), Time Above Range (TAR), Glycemic Variability (GV), and HbA1c as predictor of glycemic control in children and adolescents with Type 1 Diabetes Mellitus

      hrp0097p2-126
    • Celiac and Autoimmune thyroid disease in patients with anti-GAD positive type 1 diabetes mellitus

      hrp0097p2-127
    • A Case of Latent Autoimmune Diabetes of Youth Initially Negative for Islet Autoantibodies

      hrp0097p2-128
    • The use of analogue insulins in children and adolescents with type 1 diabetes in Kashkadarya region

      hrp0097p2-129
    • Insulin-dependent diabetes mellitus in a young child in the structure of monogenic immune dysregulation syndrome (LRBA deficiency)

      hrp0097p2-130
    • Ketoacidosis in the newborn as a presentation of IPEX Syndrome

      hrp0097p2-131
    • Glucose monitoring systems in children and adolescents with type 1 diabetes and expectations from their use

      hrp0097p2-159
    • Demographic and clinical characteristics of children with type 1 diabetes mellitus at Notre Dames Des Secours University Medical Center Byblos Lebanon

      hrp0097p2-181
    • Evaluation of clinical outcomes in children and adolescents with type 1 diabetes switching from Insulin Glargin to Insulin Detemir

      hrp0097p2-182
    • New onset diabetes – frequency of DKA and positive islet autoantibodies at Varna’s diabetes center

      hrp0097p2-183
    • An Obese HNF1β Case Presenting with Diabetic Ketoacidosis

      hrp0097p2-184
    • DEND syndrome (Developmental delay, Epilepsy and Neonatal Diabetes) in two Pakistani Families, A Case Report

      hrp0097p2-185
    • Idiopathic Chronic Calcific Pancreatitis (ICCP) presenting with fibro calculus pancreatic diabetes (FCPD) - a rare case in a 9-year-old Sri Lankan boy

      hrp0097p2-210
    • A rare association between congenital hyperinsulinism and congenital isolated ACTH deficiency

      hrp0097p2-211
    • Frequency of autoimmune diseases in childhood type 1 diabetes

      hrp0097p2-235
    • Genetic evidence for a causal relationship between severe hyperlipidemia and Type 1 Diabetes

      hrp0097p2-237
    • CGK Gene nucleotide variant of uncertain clinical significance (Exon 4/10. c397G>A. p.Asp133Asn) in a pediatric patient with hyperglycemia, elevated HgA1c and negative anti-islet cell antibodies

      hrp0097p2-238
    • Fulminant Type 1 Diabetes Case With Positive Diabetes-Associated Antibodies

      hrp0097p2-240
  • Fat, Metabolism and Obesity
  • • Can Gender differently affect Growth and Metabolic Syndrome (MetS) Criteria in children with Classic Congenital Adrenal Hyperplasia (CAH)?

      hrp0097p2-31
    • The prevalence and risk factors of non-alcoholic fatty liver disease in obese and normal weight children in Latvia

      hrp0097p2-32
    • Obesity-related Hypothyroidism in Children

      hrp0097p2-33
    • Case Report: Massive Obesity secondary to a Homozygous MC4R mutation in a 3-year-old Boy

      hrp0097p2-34
    • The outcome of management for childhood obesity during COVID19 pandemic (2019-2021) in Qatar

      hrp0097p2-67
    • Gut Hormones in Malnourished infants and children: Important Role in Adaptation

      hrp0097p2-68
    • A Young Woman with Morbid Early Onset Obesity, Progressive Hypothalamic-Pituitary Dysfunction, Bilateral Optic Nerve Atrophy, and a Combination of Variations in Four Genes Involved in Hypothalamic Satiety Signaling Pathways

      hrp0097p2-69
    • Association of osteoprotegerin and metabolic status in obese children

      hrp0097p2-70
    • The first case report of a child with progeria syndrome in Oman

      hrp0097p2-71
    • Evaluation of Triglycerides to High Density Lipoprotein Cholesterol Ratio (TG/HDL-C) as a Predictor of Insulin Resistance among Obese Children and Adolescents, single center experience

      hrp0097p2-112
    • Body composition changes during interventions to treat obesity in children

      hrp0097p2-132
    • Integrated care for childhood obesity within the medical and municipal domain

      hrp0097p2-133
    • Short-term data of the newly opened pediatric obesity center in Ankara

      hrp0097p2-134
    • The influence of Vitamin D on the physical fitness of obese children

      hrp0097p2-135
    • Correlations between the degrees of obesity and dyslipidemia in a pediatric population from Romania

      hrp0097p2-177
    • The association between physical activity and 25-OH vitamin D levels

      hrp0097p2-207
    • THe relationship between sunlight exposure and insulin resistance

      hrp0097p2-208
  • Fetal, Neonatal Endocrinology and Metabolism
  • • Hyperinsulinaemic Hypoglycaemia in Term Neonates Without Known Risk Factors Leading to Neurological Damage: A Case Series of 5 Patients From Two Regional Centres in the UK

      hrp0097p2-22
    • Congenital hyperinsulinism; challenges in management and diagnosis. An experience from LMIC

      hrp0097p2-72
    • When the infant makes the diagnosis of Biermer's disease of his mother

      hrp0097p2-73
    • A recessive heterozygous mutation in ABCC8 gene as the cause of severe congenital hyperinsulinism: a case report

      hrp0097p2-74
    • Foetal exposures to endocrine-disrupting chemicals. INMA-ASTURIAS COHORT. SPAIN

      hrp0097p2-75
    • The complexity of Hyperinsulinism in newborns

      hrp0097p2-113
  • GH and IGFs
  • • The Interaction between Growth Hormone (GH) -Insulin-like Growth factor 1 (IGF1) axis and Immune Systems in Infants and Children During undernutrition: Newly Discovered Pathological mechanisms

      hrp0097p2-47
    • The Value of using IGF1/Growth Hormone Peak Ratio in Children with Idiopathic Short Stature

      hrp0097p2-48
    • Metabolic parameters in a series of patients with Prader-Willi syndrome treated with recombinant growth hormone

      hrp0097p2-107
    • Acromegaly in a 14-year-old girl with pituitary adenoma

      hrp0097p2-108
    • A real world experience of using Long acting Growth Hormone (Somatrogon) in Children with Growth Hormone Deficiency

      hrp0097p2-109
    • Are there sex differences among patients to whom a growth hormone (GH) test with clonidina stimulus was required during the study of short stature?

      hrp0097p2-115
    • Human milk insulin-like growth factors and Cyclic glycine-proline (cGP) concentrations in relation to infantile and childhood growth

      hrp0097p2-136
    • rhGH treatment in SGA patient with spondylo-epi-metaphyseal chondrodysplasia

      hrp0097p2-137
    • Growth hormone deficiency and Glycogen storage disease type 0 in a girl with short stature and hypoglycemia: a case report

      hrp0097p2-138
    • Maternal Factors affecting Human milk insulin-like growth factor (IGF) (HMIGF1) level

      hrp0097p2-161
    • Correlation between IGF-1 at diagnosis and adult height in children with short stature

      hrp0097p2-162
    • Taller in One Year: Early Intervention Emphasize of Growth Hormone Therapy in Children with Growth Hormone Deficiency

      hrp0097p2-163
    • Etiology and characteristics of children with short stature in endpcrinology department

      hrp0097p2-201
    • Study of different anthropometric factors on the patients with growth hormone deficiency before and after treatment

      hrp0097p2-227
    • Growth Hormone insensitivity (Laron syndrome): Report of a case

      hrp0097p2-234
  • Growth and Syndromes
  • • Variations in body composition, IGF1 and Cyclic glycine-proline (cGP) concentrations in breastfed vs formula fed infants during infancy period

      hrp0097p2-5
    • Maternal, placental and fetal IGF-1 and IGFBP in Obese pregnancies and the effect on fetal/infantile growth

      hrp0097p2-6
    • Survey of the Prevalence of Balance Issues in Turner Syndrome

      hrp0097p2-7
    • Growing Tall and Staying Slim During a Pandemic: The Power of rGH

      hrp0097p2-8
    • A novel COL11A1 gene mutation in a patient with short stature mimicking Noonan syndrome

      hrp0097p2-9
    • Overgrowth in a 12-years-old boy with distal chromosome 16 duplication syndrome

      hrp0097p2-10
    • GH-IGF-1 axis in PTPN11 and non-PTPN11 Noonan syndrome: Effects on growth and response to GH treatment

      hrp0097p2-11
    • A novel heterozygous pathogenic variant in the HMGA2 gene causing Silver-Russell Syndrome, a case-report

      hrp0097p2-12
    • Transition of patients treated with growth hormone – case series

      hrp0097p2-13
    • Unmet needs and challenges experienced by patients with growth disorders and their caregivers: A patient expert view

      hrp0097p2-14
    • Autosomal dominant inherited VUS 3 in the fibrillin 2 gene in a patient with tall stature

      hrp0097p2-15
    • Clinical heterogeneity of Kabuki Syndrome in a cohort of pediatric Romanian patients

      hrp0097p2-16
    • Efficacy and safety of recombinant growth hormone therapy in a girl with a Loeys-Dietz syndrome

      hrp0097p2-17
    • Central precocious puberty in KBG syndrome due to a rare ANKRD11 variant

      hrp0097p2-18
    • Gonadotropin and Estradiol levels in Turner Syndrome: does an old dog teach new tricks?

      hrp0097p2-19
    • Temple Syndrome in monozygotic twins with GH and GnRHa treatment in one twin

      hrp0097p2-20
    • Schaaf-Yang syndrome: Report of two cases

      hrp0097p2-21
    • Small for age gestational: puberty status, metabolism and growth of an epipeg-premeb clinical cohort at 7-9 years after onset

      hrp0097p2-81
    • Adipocyte Hormones (Leptin- Adiponectin) Changes and Their Possible Effects on Metabolism, and Immunity During Malnutrition; New Mechanisms of Action

      hrp0097p2-82
    • Therapeutic compliance in 100 children treated with growth hormone

      hrp0097p2-83
    • Two cases of Wiedemann-Steiner syndrome including novel gene mutation

      hrp0097p2-84
    • Challenges in treating delayed puberty in a girl with Marfan syndrome

      hrp0097p2-85
    • Wolf-Hirschhorn syndrome: severe short stature and growth hormone deficiency

      hrp0097p2-142
    • Improving detection of rare overgrowth syndromes referred to the endocrinology ward for analysis of acromegaly

      hrp0097p2-143
    • Beyond the surface: A Tale of Uncovering the True Diagnosis

      hrp0097p2-144
    • Impact of Undernutrition and Short Stature on The Quality of Life (QOL) in Children and adolescents with Beta thalassemia Major (BTM)

      hrp0097p2-194
    • Morbid obesity revealing a rare genetic disease

      hrp0097p2-195
    • A case of ACAN mutation: from onset to final stature

      hrp0097p2-196
    • Height control using estradiol valerate considering chronological and bone age in patient with Marfan Syndrome

      hrp0097p2-222
    • The Impact of Different Karyotypes on the Response to Growth Hormone Therapy in Girls with Turner Syndrome

      hrp0097p2-223
    • Silver-Russell Syndrome: knowing how to think about it

      hrp0097p2-230
    • Growth hormone treatment of short SGA children – experience of tertiary clinic in Bulgaria

      hrp0097p2-231
  • Multisystem Endocrine Disorders
  • • Prevalence of Malnutrition and Underweight in Children and Adolescents with Beta-Thalassemia Major (BTM)

      hrp0097p2-1
    • Genetic test is useful in diagnosing nephrogenic diabetes insipidus

      hrp0097p2-2
    • Consequences of Hypogonadism and Potential Benefits of Sex Steroid therapy (HRT) in Children and Adolescents with Beta Thalassemia Major (BTM)

      hrp0097p2-86
    • Undernutrition, abnormal body composition, and impaired linear growth in children and adolescents with Beta-Thalassemia Major: possible contributing factors

      hrp0097p2-87
    • A glimpse of the presentation of Pseudohypoparathyroidism in children.A Case series from a tertiary care Pediatric Endocrine center in Sri Lanka

      hrp0097p2-88
    • Autoimmune polyendocrine syndrome type 1 (APECED):Case Report

      hrp0097p2-89
    • Autosomal dominant hypocalcemia: A diagnostic and therapeutic challenge

      hrp0097p2-90
    • Clinical Characteristics of patients seropositive for any one or more of 4 serological tests of celiac disease in a Singaporean paediatric endocrinology clinic

      hrp0097p2-152
    • Assessment of some endocrinal disorders in children finished cancer treatment: a single center study

      hrp0097p2-153
    • Hypoglycemia in a 9-month-old infant due to hyperinsulinism by ABCC8 variant

      hrp0097p2-154
    • Evaluation Of Bone Health And Endocrine Functions İn Children With Mucopolysaccharidosis

      hrp0097p2-228
  • Pituitary, Neuroendocrinology and Puberty
  • • Evaluation of etiology and clinical feature of precocious puberty among children presenting in a pediatric endocrinology department in a tertiary care hospital

      hrp0097p2-23
    • Familial growth hormone deficiency associated with a PROKR2 gene variant

      hrp0097p2-24
    • Coexistence of Pituitary Stalk Interruption Syndrome, Sacrococcygeal Teratoma and Horseshoe Kidney

      hrp0097p2-25
    • Craniopharyngioma-related hypothalamic obesity: efficacy of bariatric surgery in two adolescents

      hrp0097p2-26
    • Use of the arginine-stimulated copeptin test in polyuric syndrome in paediatrics. Experience in three patients

      hrp0097p2-27
    • Hipothalamic syndrome in craniopharyngioma: pre and post-surgery

      hrp0097p2-28
    • A case of congenital central hypothyroidism with complete growth hormone deficiency caused by a novel nonsense mutation in the IGSF1 gene

      hrp0097p2-35
    • Unusual presentation of pheochromocytoma (PCC) and paraganglioma (PGL) in two sisters with von Hippel Lindau disease (VHL)

      hrp0097p2-36
    • A male case of peripheral precocious puberty caused by testotoxicosis

      hrp0097p2-37
    • Combined pituitary hormone deficiency caused by a missense de novo variant in FGFR1

      hrp0097p2-38
    • A Case Report of a 10-Year-Old Girl with Pituitary Abscess

      hrp0097p2-39
    • Peripheral Precocious Puberty due to Exogenous Estradiol in a 3-Year-Old Girl: A Case Report

      hrp0097p2-91
    • A case of pituitary stalk interruption syndrome of normal height with chronic fatigue and delayed puberty

      hrp0097p2-92
    • Diabetes insipidous and non langerhans histiocitosis, a challenging diagnosis

      hrp0097p2-93
    • Diagnostic and predictive value of brain magnetic resonance imaging in Algerian children with growth hormone deficiency

      hrp0097p2-94
    • Short-term impact of therapy with GNRH analogues on the growth of female children with central precocious puberty: a retrospective study of the last 20 years

      hrp0097p2-95
    • Clinical observation of post-menarche in idiopathic central precocious puberty or rapidly progressive puberty treated by GnRHa and GnRHa+rhGH

      hrp0097p2-145
    • Some descriptive characteristics of hypopituitarism in children and adolescents in Armenia

      hrp0097p2-146
    • Posterior Sellar Spine - an unusual cause of precocious puberty

      hrp0097p2-147
    • Diagnostic dilemma in an adolescent boy with hypopituitarism – pituitary apoplexy or Rathke cleft cyst?

      hrp0097p2-148
    • Growth arrest due to multiple hormonal deficiencies caused by hemorrhagic apoplex of a Rathke cleft cyst - a rare difefrential diagnosis of acquired childhood pituitary insufficiency

      hrp0097p2-149
    • Precocious puberty: let's talk about the north of Algeria!!

      hrp0097p2-164
    • Peripheral precocious puberty in a hospital in eastern Algeria

      hrp0097p2-165
    • Precocious thelarche and menarche in 5 years old girl – McCune - Albright syndrome – our experience

      hrp0097p2-197
    • Idiopathic diabetes insipidus: beyond the initial diagnosis

      hrp0097p2-198
    • Diabetes insipidus in pediatric onset langerhans cell histiocytosis with excellent response to treatment

      hrp0097p2-232
    • McCune-Albright Syndrome: knowing how to think about it

      hrp0097p2-233
    • Congenital Hypopituitarism: a pathology not to be ignored

      hrp0097p2-236
  • Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology
  • • Mass of the inguinal region, from casual finding to genetic diagnosis

      hrp0097p2-40
    • 5α-Reductase Type 2 Deficiency over three decades in a single center

      hrp0097p2-41
    • Persistent Müllerian duct syndrome and the identification of a yet unreported homozygous mutation in AMHR2 gene

      hrp0097p2-43
    • New variant in DHX37 associated to 46,XY gonadal dysgenesis

      hrp0097p2-44
    • Case series: WT 1 mutation- an important differential in 46, XY disorders of sexual development (DSD)

      hrp0097p2-49
    • A Rare Diagnosis in a Virilized Adolescent with a 46,XX Karyotype: Gonadoblastoma with Dysgerminoma

      hrp0097p2-50
    • Clinical outcomes and genotype-phenotype correlations in patients with complete and partial androgen insensitivity syndromes

      hrp0097p2-96
    • Single Center Experience in Patients with Mixed Gonadal Dysgenesis

      hrp0097p2-97
    • Novel genetic variant in NR5A1 (SF1) gene with clinical presentation of Hypergonadotropic hypogonadism

      hrp0097p2-98
    • Three cases of Leydig cell tumor with different clinical presentation

      hrp0097p2-99
    • Diverse Phenotypes of Three Cases of Partial Androgen Insensitivity Syndrome with Androgen Receptor Gene Variants

      hrp0097p2-100
    • Change in timbre of voice as one of the signs of hyperandrogenism in a 11-year-old girl- a case report

      hrp0097p2-101
    • Ovotesticular Disorder of Sexual Development Diagnosed in Adolescence – a Twins Case Report

      hrp0097p2-102
    • Clitoromegaly as a manifestation of neurofibromatosis type 1

      hrp0097p2-103
    • Gender dysphoria, social transition, mental health and metabolites of cortisol among transgender and gender non-conforming youth in one of Polish hospitals

      hrp0097p2-104
    • Self-perception of voice in trans girls adolescents depends on pubertal stage blockage

      hrp0097p2-105
    • Evaluation of trends and care of transgender young assisted in a reference unit

      hrp0097p2-106
    • Tailored daily transdermal testosterone treatment before hypospadias surgical repairing: preliminary data of a single center study

      hrp0097p2-114
    • 46,XY disorders of sex development associated with MAP3K1variants: Case and review of the literature

      hrp0097p2-150
    • A case of male pseudoermaphroditism (46,XY DSD) in an adolescent with a novel de novo NR5A1 gene variant

      hrp0097p2-158
    • Value of antimullerian hormone (AMH) in the diagnosis of precocious puberty: revaluation of the covid-19 post-pandemic cohort

      hrp0097p2-166
    • SRY-positive 45, X male with monoorchism and hypospadias

      hrp0097p2-180
    • Adolescent girl with premature ovarian insufficiency due to X-chromosome deletion

      hrp0097p2-199
    • Familial Male-limited Precocious Puberty. Case report from Mexico City

      hrp0097p2-200
    • Spectrum of phenotypic features variation in XY DSD patients with NR5A1 mutation: case series

      hrp0097p2-224
    • Oligomenorrhea in two girls with familial mediterranean fever: how chronic inflammation can impair ovarian cycle

      hrp0097p2-225
    • Classical CAH girls having early intervention and puberty development

      hrp0097p2-226
  • Thyroid
  • • Evaluation of the clinical progress of hashimoto thyroiditis in childhood

      hrp0097p2-45
    • Admission Characteristics and Rates of Transient/Permanent Hypothyroidism in Infants from Congenital Hypothyroidism Screening

      hrp0097p2-46
    • A 5-year study on the incidence of Congenital Hypothyroidism in Gertrude’s Children’s Hospital Nairobi, Kenya

      hrp0097p2-110
    • Thiamine responsive megaloblastic anemia with hypothroidism, a puzzling association, a case report from LMIC

      hrp0097p2-111
    • Congenital hypothyroidism in children with Sotos syndrome

      hrp0097p2-151
    • Subclinical hypothyroidism in children: epidemiological study of 30 patients

      hrp0097p2-167
    • Total thyroidectomy for thyrotoxicosis in a girl with dysphonia

      hrp0097p2-178
    • Papillary thyroid carcinoma of the solitary hot nodule in a pediatric patient

      hrp0097p2-179
    • A Case of Neonatal Thyrotoxicosis born to mother after thyroidectomy for Grave’s disease

      hrp0097p2-204
    • Congenital hypothyroidism – the experience on a group of pediatric patients since diagnosis

      hrp0097p2-205
    • Hypothyroidism without elevation of thyroid-sttmulating hormone associated with oxcarbazepine use in children and adolescents

      hrp0097p2-206
    • What is the risk on intelligence in children with dysthyroiidism?

      hrp0097p2-229
    • Hyperthyroidism in children

      hrp0097p2-239
  • Late Breaking
  • • Primary hyperparathyroidism in children

      hrp0097p2-241
    • Endocrine manifestations of the COVID-19 pandemic in children and adolescents: a scoping review

      hrp0097p2-242
    • Endocrine Outcomes in Bardet-Biedl Syndrome from a Large Single-Centre Paediatric Multidisciplinary Clinic

      hrp0097p2-243
    • The impact of weight for length on the assessment of congenital growth hormone deficiency

      hrp0097p2-244
    • Neonatal Hypocalcaemia and association with maternal Magnesium sulphate (MgSO4) administration in a single center neonatal unit

      hrp0097p2-245
    • Results from a Multi-Stakeholder Meeting on Medical Devices in Paediatric Type I Diabetes

      hrp0097p2-246
    • Fluid Selection in The Management of Diabetic Ketoacidosis in Children: A Systematic Review

      hrp0097p2-247
    • Pediatric Hyperthyroidism in the Time of COVID-19: An Updated Presentation Analysis

      hrp0097p2-248
    • Longitudinal Improvements in Health-Related Quality of Life among Children and Adolescents enrolled in Canadian Pediatric Weight Management Programs

      hrp0097p2-249
    • Update on the Etiological Diagnosis of Central Precocious Puberty in Both Sexes

      hrp0097p2-250
    • Environmental sustainability of three injection pens used for administration of recombinant human growth hormone

      hrp0097p2-251
    • Pump management of genetic and autoimmune diabetes under 1 years old: two case reports

      hrp0097p2-252
    • Challenges and Outcomes of Using Insulin Analogues in Children with Diabetes in Low- and Middle-Income Countries

      hrp0097p2-253
    • Decrease in the percentage of eutrophic adolescents in Brazil, temporal evaluation from 2010 to 2022

      hrp0097p2-254
    • Phenolic Endocrine Disruptors as Potential Risk Factors for Early Onset Thelarche: Insights from a Population-Based Study

      hrp0097p2-255
    • Influencing Factors of Growth Hormone Treatment in Short Stature Children Born Small for Gestational Age in China: a single-center, cross-sectional survey

      hrp0097p2-256
    • A cohort study on growth hormone therapy in Chinese children with Prader-Willi syndrome – the effect of treatment age

      hrp0097p2-257
    • Long-term Safety and Effectiveness of Growth Hormone in Pediatric Patients with Growth Disorders in Korea: A 10-Year Interim Analysis of the LG Growth Study

      hrp0097p2-258
    • Saudi experience of long term treatment for Laron syndrome with IGF-1 injection over 22 years, cohort study

      hrp0097p2-259
    • Pseudohypoaldosteronism: a challenging diagnosis with management pitfalls

      hrp0097p2-260
    • Rare cause of Endocrine Hypertension - Apparent Mineralocorticoid Excess with a novel mutation

      hrp0097p2-261
    • A new case of Malan Syndrome with de novo NFIX sequence variants and a review of the literature

      hrp0097p2-262
    • The gene diagnostic challenge of extrem early-onset obesity before 6 years old

      hrp0097p2-263
    • Improvement in the nutritional status of Brazilian children under five years of age, evaluation from 2010 to 2022

      hrp0097p2-264
    • in vitro metabolic homeostatic activity of brown adipose tissue-derived exosomes

      hrp0097p2-265
    • Rabson Mendenhall syndrome (RMS)- Insulin resistance type A. We need to act faster than the disease. Case Report

      hrp0097p2-266
    • Intellectual outcome in children with early treated congenital hypothyroidism

      hrp0097p2-267
    • Clinical characteristics, molecular genetics analysis results and long-term follow-up of a large cohort of congenital hyperinsulinism from Turkey: A nationwide cross-sectional study

      hrp0097p2-268
    • Are Serum MOTS-c Levels and MOTS-c m.1382A>C Polymorphism Related to Polycystic Ovary Syndrome?

      hrp0097p2-269
    • The effect of dulaglutide (GLP-1agonist) and metformin combination on weight loss in obese patients with and without type 2 diabetes. Gold combination?

      hrp0097p2-270
    • Craniosynostosis in Patients With X-Linked Hypophosphatemia: a monocentric experience

      hrp0097p2-271
    • Is screening for vitamin D deficiency reasonable or should we supplement at risk patients?

      hrp0097p2-272
    • Key parameters at puberty onset can help distinguish self-limited delayed puberty from congenital hypogonadotrophic hypogonadism

      hrp0097p2-273
    • Familial Chylomicronaemia Syndrome; A Challenging Condition in Pre-School Aged Children

      hrp0097p2-274
    • Comparison of efficacy and safety of Leuprolide acetate depot 3.75 mg four-weekly versus 11.25 mg twelve-weekly in girls with central precocious puberty: A randomized-prospective study

      hrp0097p2-275
    • Olfactory bulbs and genetic defects in adolescents with Kallmann syndrome and normosmic hypogonadotropic hypogonadism

      hrp0097p2-276
    • Evaluation of body composition and microcirculation in children and adolescents with growth hormone deficiency: effects of replacement therapy

      hrp0097p2-277
    • Endocrine dysfunction in Charge Syndrome – short case series

      hrp0097p2-278
    • The narrative of a patient with leptin receptor deficiency: personalized medicine for a rare genetic obesity disorder

      hrp0097p2-279
    • Prevalence of Childhood Obesity Among Children Visited Paediatric Outpatient Clinics in Oman - A Single Centre Experience

      hrp0097p2-280
    • Monogenic Causes of Early-Onset Obesity in Saudi Pediatric Patients: A Retrospective study

      hrp0097p2-281
    • Impact of COVID-19 pandemic on vitamin D status in a Portuguese pediatric population: a comparation of pre-pandemic and pandemic periods

      hrp0097p2-282
    • Evaluation of body composition in Brazilian children and adolescents with X-linked hypophosphatemic rickets

      hrp0097p2-283
    • A new approach to estimate bone mineral density in pediatric subjects: Radiofrequency ecographic multi spettrometry (REMS). A comparison with DEXA.

      hrp0097p2-284
    • Combined treatment with leuprolide acetate and burosumab in X-linked hypophosphatemic rickets and precocious puberty: a therapeutic response

      hrp0097p2-285
    • Wilson disease diagnosed incidentally by targeted gene panel sequencing with severe obesity

      hrp0097p2-286
    • Central diabetes insipidus in paediatric cerebral tumors: clinical and radiological features

      hrp0097p2-287
    • Validation of utility of a single LH measurement 40 minutes after depot Leuprolide acetate 3.75 mg and 11.25 mg in assessing gonadotropic activity in girls with CPP: Comparison with a standard GnRH stimulation test at diagnosis and during treatment.

      hrp0097p2-288
    • The grey area in treatment of progressive short stature in patient with heterozygous NPR2 mutation

      hrp0097p2-289
    • Ovarian steroid cell tumor in a very young girl: clinical and genetic aspects

      hrp0097p2-290
    • Early Endocrinopathy in Childhood Cancer Survivors in a Specialized Center in Riyadh

      hrp0097p2-291
    • Accuracy of opportunistic height measurements in a tertiary pediatric hospital in Riyadh

      hrp0097p2-292
    • Unveiling the Complexities of Growth Failure: A Captivating Case of Short Stature with Coexisting Chronic Conditions

      hrp0097p2-293
    • Case Report: Untreated Congenital Hypothyroidism associated with hypertrophic pyloric stenosis

      hrp0097p2-294
    • Metabolic and growth outcome of two-years growth hormone treatment in children born small for gestational age: a retrospective study

      hrp0097p2-295
    • Cryptorchidism, and hormones in patients with androgen insensitivity syndrome and 5alpha-reductase type 2 deficiency

      hrp0097p2-296
    • Triglyceride glucose index, Triglyceride to high-density lipoprotein cholesterol ratio and pediatric NAFLD fibrosis index is the most valuable combination of criteria to detect fatty liver disease in overweight/obese boys

      hrp0097p2-297
    • Insulin-like Growth Factor-1 as a Screening Tool for Central Precocious Puberty

      hrp0097p2-298
    • Comparative of serum estradiol levels in girls with different types of precocious puberty by liquid chromatography tandem-mass spectrometry and chemiluminescence immunoassay method

      hrp0097p2-299
    • Short stature and IGF-1 resistance - unexpected association of Wolf-Hirschhorn Syndrome

      hrp0097p2-300
    • Progression in height and bone age during the first year of long-term growth hormone therapy in pre adolescent GHD children

      hrp0097p2-301
    • ESPE School Sharing Knowledge for Saving Patients' Lives: Empowering Pediatric Endocrinologists in Armenia

      hrp0097p2-302
    • The link between birthweight, obesity and insulin resistance

      hrp0097p2-303
    • Metabolic syndrome in overweight and obese children

      hrp0097p2-304
    • Precocious puberty and fluctuating β-HCG levels in a boy leading to diagnoses of klinefelter syndrome and mediastinal germ cell tumor

      hrp0097p2-305
    • Infancy onset hypocalcemia due to maternal vitamin D deficiency

      hrp0097p2-306
    • Burosumab Therapy response in a family with X-Linked Hypophosphatemic Rickets

      hrp0097p2-307
    • The use of growth hormone in children and its effect on the thyroid function at Benghazi children hospital

      hrp0097p2-308
    • The making of the EndoWatch: A new device for Early Monitoring of Hypothalamic imbalances

      hrp0097p2-309
    • Exploration of rapidly progressive puberty early prediction in girls

      hrp0097p2-310
    • Diagnostic challenges of congenital adrenal hyperplastic (CAH) in a tertiary care hospital of resource limited country

      hrp0097p2-311
    • Clinical and Genotypic characteristics of cases of Congenital Adrenal Hyperplasia due to 11- Beta Hydroxylase Deficiency at Alexandria University Children’s Hospital

      hrp0097p2-312
    • Oral Benfotiamine 300 mg Versus Intramuscular Thiamine in Diabetic Patients with Peripheral Neuropathy

      hrp0097p2-313
    • Evaluation of the usefulness of antymüllerian hormone and inhibin B as markers of ovarian reserve in girls with hyper- and hypogonadotropic hypogonadism

      hrp0097p2-314
    • A case report of a novel mutation in AR gene in two sisters with 46-XY Karyotype

      hrp0097p2-315
    • Family case of constitutional delay of puberty

      hrp0097p2-316
    • "MRKH Type 2 with Menstruation: Unraveling an Unusual Case"

      hrp0097p2-317